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ABSTRACT 
The purpose of this project was to develop innovative assessment and treatment protocols for 
clinical research on performance-specific Social Anxiety Disorder (SAD).  The initial step was to 
conduct an investigation of OEI (Observed and Experiential Integration; a trauma-root-focused 
therapy) and BRAIN (Breathing, Relaxation, Autogenics, Imagery, and grouNding; a trauma-
symptom-focused therapy) on performance-specific SAD.  Similarities between trauma and 
anxiety symptoms suggest that there can be a traumatic cause to SAD (Calamaras, Anderson, 
Tannenbaum, & Zimand, 2014; Erwin et al., 2006; Stein, Walker, & Forde, 1996; Wild, 
Hackmann, & Clark, 2008).  This was a pilot test to explore the assessment and treatment 
protocols as they related to specificity and sensitivity of measures.  Descriptive analyses in this 
pilot study revealed connections between treatment types and symptom processes which were 
activated.  Symptoms can be distinguished as: (a) narrow spectrum symptoms, such as speaker 
confidence and public speaking behaviour; (b) psychophysiological symptoms, such as 
electrodermal activity; or (c) broad spectrum symptoms, such as general anxiety and depression.  
In this pilot study, both trauma-root-focused and trauma-symptom-focused treatments resulted in 
improvements in: (a) narrow spectrum symptoms of speaker confidence and public speaking 
behaviour.  Additionally, in response to trauma-root-focused treatment: (a) broad spectrum 
symptoms improved and (b) psychophysiological activation associated with past traumatic social 
experiences was alleviated (Porges, 2007; van der Kolk, 2001, 2002; van der Kolk, B. A., 
Hopper & Osterman, 2001).  As a result of this study, it is suggested that diverse types of 
measurements (including self-report, behaviour sampling, and psychophysiological measures), 
will be helpful for understanding (a) broad spectrum, (b) narrow spectrum, and (c) 
psychophysiological symptoms.  The potential traumatic origin for performance-specific SAD 
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was supported by results of the descriptive analyses in this study.  The findings of this study will 
also be useful for establishing measurement parameters for clinical research on social anxiety.  If 
these patterns continue to be supported by additional research, such results will help: (a) those 
with performance-specific SAD, (b) clinicians, and (c) future clinical researchers.
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CHAPTER 1: INTRODUCTION 
Imagine standing on a stage.  In front of you is a full auditorium of eager listeners waiting 
to hear a dynamic speech.  Does your heart race?  Do your palms sweat?  Does the first line of 
your speech leave your mind, as you worry about losing your place or forgetting your speech?  If 
your answer is “yes” to any of these questions, you are not alone.  Community surveys report 
that up to one-third of people experience anxiety related to public speaking (Kessler, Stein, & 
Berglund, 1998; Stein, Walker, & Forde, 1996).  
The fear of negative evaluation by others is at the core of performance-specific Social 
Anxiety Disorder (SAD; American Psychological Association, 2013).  SAD is the broader 
anxiety disorder under which public speaking anxiety (PSA) falls.  This type of social anxiety 
shows itself most in public speeches or performances, but can be evident in places such as 
classes, meetings, or social engagements.  There are many physiological, emotional, and 
behavioural responses to this fear, including: worry, anxiety, nervousness, sweating, shaking, or 
dizziness.  These fears and physiological responses are usually associated with (a) worries about 
other people noticing the nervousness, or (b) fear of embarrassment (Calamaras, Anderson, 
Tannenbaum, & Zimand, 2014).   
Researchers have sought to understand the impact of performance-specific SAD.  In a 
cluster analysis, PSA was found to be the most common subtype within three subtypes of SAD: 
(a) generalized, (b) non-generalized, and (c) specific phobia, including PSA (Furmark, Tillfors, 
Stattin, Ekselius, & Fredrikson, 2000).  Public speaking fears made up 40% of the social phobia 
group.  Mannuzza et al. (1995) found that PSA co-occurred in 88% of participants with 
Generalized Social Anxiety, and 79% of those suffering from non-generalized Social Phobias.  
The magnitude of this problem warrants exploration regarding effects of PSA. 
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Calamaras et al. (2014) found that those with performance-specific SAD had lower 
income, more unemployment, and less education.  Stein et al. (1996) found similar implications 
of anxiety related to public speaking in a community sample.  Those who reported PSA had 
lower incomes, higher rates of unemployment, and less education.  Half of these individuals had 
only PSA and no comorbid anxieties.  These correlations do not confirm that PSA caused these 
negative outcomes, but subjective interview findings by Stein et al. support the limiting influence 
of such fears on ability to pursue educational, career, social, and other major goals.  The 
collection of these findings supports a reciprocal effect, and constitutes sufficient reason to 
research and develop effective treatments for performance-specific SAD.  Treatments for 
performance-specific SAD will help individuals achieve their educational and employment 
potentials.   
Many approaches have been used to treat SAD.  These include: Cognitive Behavioural 
Therapy, Exposure Therapy, combined Exposure Therapy and Cognitive Restructuring, and 
mindfulness- and acceptance-based therapy.   There may, however, be merit in using trauma 
treatments to treat such anxiety, as results of several studies suggest that anxiety disorders can be 
traced back to childhood abuse or socially traumatic events, leading to symptoms similar to those 
of Posttraumatic Stress Disorder (PTSD).  Erwin et al. (2006) found that more than 95% of their 
sample of patients with SAD reported past traumatic events.  Of this group, 78% reported that 
these traumatic experiences caused symptoms of avoidance, re-experiencing, or hyperarousal 
lasting more than three months.  Wild, Hackmann, and Clark (2008) found that memory re-
scripting of socially traumatic memories helped individuals with SAD.  Participants were less 
likely to accept the beliefs which arose from their memories, and had lower anxiety scores during 
visualizations of their feared social situations than those in a control group.  Results of these 
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trauma-informed studies of anxiety reveal the contribution of prior trauma to the development of 
later anxiety disorders, suggesting that trauma treatment may be a helpful approach for 
performance-specific SAD.  
Two types of treatments were used to address the traumatic aspect of performance-
specific SAD in this study.  The first is Observed and Experiential Integration (OEI; Bradshaw, 
Cook, & McDonald, 2011) which focuses on treating the traumatic root (original traumatic 
experience or cause) of the anxiety.  The second is a mindfulness, relaxation, and grounding 
protocol known as BRAIN (Breathing, Relaxation, Autogenics, Imagery, and grouNding) based 
on techniques described by Davis, Eshelman, and McKay (1995) and Dennison and Dennison 
(1986, 1994).  This treatment focuses on neutralizing the symptoms of trauma as they arise.  The 
purpose in using these two types of treatment is to see how they differently effect how 
participants experience changes in their performance-specific SAD.  
OEI is a new treatment for psychological trauma (Bradshaw, Cook, & McDonald, 2011).  
This approach has been subjected to two randomized controlled trials (Bradshaw, McDonald, 
Grace, Detwiler, & Austin, 2014; Bradshaw et al., 2017) and found to be an effective treatment 
for PTSD.  OEI has been used in hundreds of thousands of hours of clinical practice over a 
period of 20 years (R. A. Bradshaw, personal communication, June 15, 2015).  Within these 
hours, OEI has been used successfully to treat performance-specific SAD which manifested as 
public speaking anxiety, usually in 1-3 sessions.  To follow up these promising clinical 
observations, this study constitutes the first formal investigation of OEI to treat SAD.   
BRAIN helps users to calm their bodies and minds when faced with stressors or when 
practicing mindfulness (Davis, Eshelman, & McKay, 1995).  The main ways this treatment 
works with the physiological trauma symptoms is through: (a) diaphragmatic breathing, (b) 
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progressive muscular relaxation, (c) autogenics, (d) imagery, and (e) grounding.  There is some 
evidence this treatment can help individuals cope with their current trauma symptoms (Taylor et 
al., 2003).  
This study was an initial effort to see how a trauma-root focused and a trauma-symptom-
focused treatments interacted with performance-specific SAD.  This pilot study was designed to 
prepare research guidelines and assessment protocols for future research investigating factors not 
addressed by current theories of social anxiety.  The main reasons for this pilot study were to 
assess sensitivity and specificity of measures, given the heavy response demand of multiple 
complex measures in this study (Appendix A).   
Different dimensions of assessments were used to see how treatments affected the 
symptoms of performance-specific SAD.  These assessments included: (a) self report, (b) 
behavioural, and (c) psychophysiological measures.  Such an involved assessment protocol had 
the potential for a high response demand on participants.  This pilot study increased 
understanding of the importance of multimodal assessment despite high response demand.  
Readers wanting to view the list and order of assessments used in this study should see Appendix 
A.  
A further goal of this study was to alleviate performance-specific SAD in participants, so 
they could enroll in broader public speaking skill development programs (e.g., Toastmasters) or 
at least be more comfortable using skills they currently possess.  As these individuals gain public 
speaking skills and confidence, they can pursue education, career, and social goals which were 
previously unachievable. 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  5 
CHAPTER 2: LITERATURE REVIEW 
 There is a great deal of literature on anxiety symptoms and treatment.  Literature regarding 
the following topics will be reviewed in this chapter: (a) Social Anxiety Disorder (SAD) with 
performance-only specifier, (b) current treatments for SAD, (c) the commonly missed traumatic 
aspects of SAD, and (d) current trauma treatments.  The following sections of this chapter 
describe the treatments used in this study: (a) Observed and Experiential Integration (OEI) and 
(b) BRAIN (a grounding and relaxation protocol).  The chapter concludes with (a) rationales for 
the study, (b) objectives, (c) hypotheses, and (d) research questions. 
Social Anxiety Disorder (Social Phobia) with Performance-Only Specifier  
 Social Anxiety Disorder (SAD) is the broad term for a group of fears related to social 
situations (American Psychological Association, 2013).  The diagnostic criteria for SAD 
according to the DSM-5 is: (a) fear about social situations (one or more) where there is fear of 
scrutiny by others; (b) fear of acting in a way which will show anxiety symptoms; (c) the 
situation always prompts this fear response; (d) contexts which would cause this anxiety are 
avoided; (e) the fear/anxiety is greater than the threat of the actual event; (f) the anxiety, fear, or 
avoidance is present for at least six months; (g) this fear/anxiety causes clinically significant 
distress; (h) the symptoms cannot be explained by use of a substance; (i) the symptoms cannot be 
better explained by another disorder; and (j) any other medical conditions are clearly unrelated to 
the cause of symptoms.  This can be further specified by performance-only, in which the fears 
are specifically connected to speaking or performing in public.  
 Comorbidity.  There are mixed reports on whether performance-specific SAD is less 
comorbid with other disorders than more general social fears, or if it is equally comorbid.  If this 
subtype is less comorbid, it becomes a perfect subtype to study for treating a pure form of 
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anxiety.  Each of the following two paragraphs address one article on comorbidity of 
performance-specific SAD.  Authors of the first article found performance anxieties to be less 
comorbid while the authors of the next article reported both to be comorbid with depression and 
more general anxiety symptoms.  
  Kessler et al. (1998) described the incidence of, and distinctions between, public speaking 
anxieties and anxieties about other social situations.  Data analyzed in the study were collected as 
part of the National Comorbidity Survey (n = 8,098) which had: (a) an age range of 15-54 years, 
(b) an 82.4% response rate, and (c) sociodemographic variables.  The researchers used the 
Composite International Diagnostic Interview to assess for Social Phobia (SP).  They evaluated 
interviewees for SP by asking participants to share their fears or avoidances of six situations: (a) 
using a washroom away from home, (b) speaking in public, (c) eating or drinking in public, (d) 
writing while someone watches, (d) talking to someone when you do not have something to say, 
and (e) talking when in front of a small group.  Data analyses revealed two subtypes: (a) 
speaking fears, and (b) more expansive social fears.  Those who had general social fears usually 
had many comorbid social fears (usually of the performance or interaction variety), while one-
third of those with speaking fears reported speaking fears in isolation.  This subtype showed 
much less comorbidity with other DSM-III-R disorders when compared to the general social fear 
subtype.  More recent references were sought to further substantiate this division; however, there 
is a marked paucity of PSA literature since the mid-1990s.  The authors found that 35.8% of 
respondents had pure speaking fears, which is much higher than the 8.5% who had only one of 
any of the other social fears in the survey.  This supports the contention that speaking fears are 
less comorbid than other social anxieties. 
 Knappe et al. (2011) also explored social phobia subtypes in terms of clinical (avoidance, 
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age of onset, comorbidities, impairments) and vulnerability factors (behavioural inhibition, 
parental rearing, and parental psychopathology).  Using the Munich-Composite International 
Diagnostic Interview they studied a population sample (n = 3,021; aged 14-24 years) for more 
than ten years.  They found two subtypes of social fears: (a) interaction, and (b) performance 
fears (such as PSA).  Both types of fears are associated with high levels of avoidance, 
comorbidity with depression or anxiety, and impairment.  The weighted percentage of 
participants who reported fear of speaking in front of others was 24.8%.  The authors also found 
that parental (multigenerational) anxiety disorders were positively associated with performance-
related social fears (such as public speaking anxiety) but this association was less evident in 
those with isolated social phobias.  Whether or not performance-specific SAD is equally or less 
comorbid than more general social anxiety, this subtype of SAD does appear to have an impact 
on the lives of those who struggle with this anxiety.  
 Impact of Performance-Specific Social Anxiety Disorder.  Considering the potential for 
limited comorbidity, one may be quick to disregard the impact of a performance-only social 
anxiety, but there are several areas of life which can be greatly effected by such a fear.  Stein et 
al. (1996) studied the prevalence, and repercussions, of social phobia in a community sample of 
499 people residing in Winnipeg, Manitoba.  Thirty-four percent of the sample reported high 
anxiety when speaking to large audiences.  Anxious thoughts reported included: (a) “doing or 
saying something embarrassing (64%); (b) “having one’s mind go blank” (74%), (c) “being 
unable to continue talking” (63%); (d) “saying foolish things or not making sense” (59%); and 
(e) “trembling, shaking, or showing other signs of anxiety” (80%).  If the diagnostic criteria for 
social phobia in the DSM-IV were applied to the data, within the group reporting public speaking 
fears: (a) 7% said such fears interfered with their abilities to find jobs, get new jobs, or be 
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selected for better jobs; (b) 4% said this interfered with their normal social interactions; (c) 14% 
said such fears interfered with their education; and (d) 17% reported their anxiety-related to 
public speaking interfered with major areas of their lives.  If the criteria for social phobia were 
broadened to include all those with anxiety related to large group public speaking, 31% said that 
fear had caused them significant distress.  They also found those with significant public speaking 
anxiety had less lucrative employment, and less education, than those without.  The fact that 
individuals have reported performance-specific SAD impacted their lives, should lead to inquiry 
about the best ways to treat SAD.   
Anxiety Treatments 
 There are many treatments being used currently to treat anxiety.  Some of the common 
treatments for social anxiety are: (a) behaviour therapy (particularly exposure), (b) cognitive 
behaviour therapy (CBT), (c) cognitive behaviour group therapy (CBGT), and (c) mindfulness 
and acceptance-based treatments.  Theory and research on these common types of treatment are 
presented in the following sections.  
 Behaviour Therapy.  The focus of Behaviour Therapy (BT) is to change behaviour by 
decreasing the occurrence of maladaptive behaviours, and increasing adaptive behaviours 
(Antony & Roemer, 2011).  Behaviours are seen as (a) functional, and (b) resulting from 
reinforcement or punishment.  Within this view, behaviours are seen as a result of the 
individual’s interaction with environment, and not an intrinsic part of the individual.  The focus 
of BT is not on early life experiences which may have contributed to the current problems but, 
instead, focuses on changing the current interactions with the environment.  Therapy is done 
using a direct approach where the therapist may give suggestions and advice.  The role of the 
client is to actively engage in treatment by practicing behavioural techniques in, and out of, 
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sessions.  Clients are active partners in therapy.  Given of the role of clients, and the nature of 
these techniques, the goal is for the clients to become their own therapists.   
 Classical Conditioning.  Classical Conditioning (CC) and extinction of fears involves 
several stages (Bouton, 2002; Hofmann, 2008).  First, a stimulus is paired with an aversive 
unconditioned stimulus (US) until the first stimulus becomes the conditioned stimulus (CS+; a 
phase known as classical conditioning).  A stimulus which is never paired with the aversive 
stimulus remains a safe stimulus.  The CS+ signals the US and will eventually independently 
cause the fear response, known as the conditioned response (CR).  When exposure to the CS+ 
happens repeatedly in the absence of the US the CR will discontinue.  This process is known as 
extinction.  This does not mean the connection between the CS and US is gone completely, but 
rather, replaced by a different response pattern based on the new context.  
 Operant Conditioning. In Operant Conditioning (OC), the strength, frequency, and form of 
behaviour is influenced by the consequences (Beck & Weishaar, 2014).  Reinforcement and 
punishment are the two forces which influence OC.  There are two types of reinforcement: (a) 
positive reinforcement is when a behaviour is followed by a desired reward and (b) negative 
reinforcement is when is when a behaviour causes an unwanted stimulus to be removed.  There 
are also two types of punishment: (a) positive punishment is when an aversive stimulus follows 
the behaviour and (b) negative punishment is when a behaviour is followed by the removal of an 
desired stimulus.  In OC, behaviour is viewed as the result of punishment or reward.   
 Other concepts relevant to OC (Beck & Weishaar, 2014) include: (a) extinction, (b) 
discrimination learning, and (c) generalization.  Extinction is said to be occurring when 
behaviour ceases to occur because the desired consequence has not occurred as a result.  
Discrimination Learning is said to be occurring when behaviour is reinforced in a certain 
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situation but not in another situation.  This can lead the individual to behave differently in 
different situations.  Generalization is said to be said to be occurring when a behaviour occurs in 
a situation other than the context in which it was learned.  Extinction, discrimination learning, 
and generalization add intricacies to OC.  
 Two-factor model of fear development and maintenance.  Classical conditioning or 
operant conditioning alone do not explain the maintenance of anxiety responses to conditioned 
stimuli, thus a two-factor model was developed (Mowrer, 1960).  The proponents of this theory 
posit that fears are developed through classical conditioning and maintained through operant 
conditioning.  Operant behaviours responsible for this maintenance are escape and avoidance.  
These behaviours allow negative reinforcement (removal of feared stimuli) and therefore the 
behaviours continue because there is no chance for clients to face prolonged or repeated 
exposure to the CS in relaxed or safe ways.  There are, however, limitations such as difficulty 
distinguishing between CS and UCS in natural environments.  Sometimes habituation (gradual 
reduction of reactivity due to exposure over time) is considered by some to be a better 
explanation for behavioural improvement than extinction (i.e., extinction learning/inhibitory 
learning; Jaycox, Foa, & Morral, 1998).  Some critics go further and suggest emotional 
processing could improve this model (Foa & Kozak, 1986; Foa & McNally, 1996).   
 Exposure Therapy Theory.  There are two key features of contemporary exposure 
therapy (ET).  The first is that clients need to be engaged with anxiety-causing stimuli repeatedly 
or for prolonged periods of time (Abramowitz, 2013).  After several exposures, responses may 
decline.  The second key feature of ET requires that clients engage in behaviours other than their 
usual fear responses (Barlow, Allen, & Choate, 2004).  These features can be shown in the 
intervention known as Systematic Desensitization (SD).  
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 Systematic desensitization involves exposing clients to progressively more anxiety-
provoking stimuli in their imaginations while sustaining relaxed states (Davison, 1968).  Starting 
with muscle relaxation may help them to get into relaxed states as they start systematic 
desensitization.  This process helps clients to use anxiety cues (such as muscle tension or other 
somatic responses) to know when to use alternative behaviours which are incompatible with 
anxiety (such as relaxation techniques).   
 There are many ways exposure therapy can be used.  These include: (a) imaginal exposure, 
(b) in vivo exposure, (c) informal exposure, (d) interoceptive exposure, (e) cue exposure, and (f) 
virtual reality exposure.  These types of exposure are explained in the following sections.  
 Imaginal exposure.  Imaginal exposure requires clients to imagine stressful stimuli to 
create non-threatening associations with feared stimuli (Farmer & Chapman, 2016).  This can be 
used in three different conditions: (a) when in vivo (live) exposure is too difficult, (b) when a 
client’s imagination is vivid enough to invoke an emotional response, and (c) before in vivo 
exposure.   
 Prolonged exposure is a type of imagined exposure where clients recount their traumatic 
experiences in great detail so they can face events without their traumatic-stress conditioned 
responses (Farmer and Chapman, 2016).  This enables clients to learn new associations with their 
memories while in safe environments, because the memories are not inherently dangerous (Foa 
& Rothbaum, 1998).  
 In vivo exposure.  In vivo exposure involves letting clients face anxiety-provoking stimuli 
in real life (Farmer & Chapman, 2016).  This can be done: (a) in a natural environment, (b) at 
home, or (c) in the therapist’s office.   
 Informal exposure.  Informal exposure is when clients are exposed to feared stimuli in 
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informally during therapy (Farmer & Chapman, 2016).  This is most often useful when clients 
are avoiding certain emotional responses because of maladaptive coping patterns.  Therapists 
typically begin by explaining how exposure will help clients reach their goals.  Therapists then 
describe when and how exposure will be used.  Finally, therapists may address exposure as the 
need arises in following sessions.   
 Interoceptive exposure.  Interoceptive exposure helps clients to engage and recognize their 
bodily sensations (Farmer & Chapman, 2016).  This type of exposure especially helps when 
clients fear certain sensations, such as those associated with panic attacks.  This can include fear 
of dizziness, in which case clients may spin until they are dizzy and come to realize they no 
serious consequences will result.   
 Cue exposure.  Cue exposure is primarily used with addiction-based struggles because 
certain cues can prompt substance use.  In the case of cue exposure, the response is blocked in 
the presence of some cue related to the substance or behaviour.  In classical conditioning terms, 
the conditioned stimulus (e.g., substance-based cue) is presented while restricting the client’s 
ability to engage in the conditioned response (e.g., taking the substance).  
 Exposure using virtual reality.  Virtual reality exposure therapy (VRET) involves facing 
feared stimuli using technology.  VR can be accessed using computers, head-mounted 
technologies, or even a fully immersive environment (Kim, Rosenthal, Zielinski, & Brady, 
2014).  The advantages of VR exposure include the ability to: (a) expose clients to situations 
which may not be possible using in vivo exposure, (b) expose clients to stimuli without leaving a 
therapist’s office, and (c) precisely control the stimuli.  Promising results have been found in 
meta-analyses on VR for treatment of various anxiety disorders. VRET treatment groups show 
greater reductions in anxiety than do wait-list (control condition) groups, and VRET treatment 
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groups show maintenance of improvements during follow-up periods (Opris et al., 2012).  
Additionally, VRET treatment groups show larger effect sizes than non-treatment (control) 
conditions (Powers & Emmelkamp, 2008).  
 Cognitive Therapy.  Cognitive Therapy (CT) is a system of strategies and techniques 
based in the theory that processing information is very important in survival (Beck & Weishaar, 
2014).  The main systems involved are: (a) cognitive, (b) behavioural, (c) affective, and (d) 
motivational.  Each of these systems are made up schemas.  Cognitive Schemas are what people 
think of: (a) themselves, (b) others, (c) their goals, (d) their expectations, (e) their memories, (f) 
their fantasies, and (g) their previous learning.  CT views disorders as a result of certain schemas, 
or biases, when incorporating new information into their lives.  There are underlying core 
beliefs, known as cognitive vulnerabilities, which contribute to the development of these 
schemas.  Previously, CT theorists saw cognitive schemas as causative of changes in other 
systems.  Current CT theorists conceptualize all the previously mentioned systems as functioning 
together and impacting each other; this is known as a mode.   
 Exposure Therapy versus Cognitive Therapy.  Ougrin (2011) conducted a meta-analysis 
comparing Cognitive Therapy (CT) and Exposure therapy (ET) for treating anxiety disorders.  
Articles chosen were randomized controlled studies comparing the efficacy of CBT and ET for 
treating Posttraumatic Stress Disorder (PTSD), Obsessive Compulsive Disorder (OCD), Panic 
Disorder (PD), and Social Phobia (SP).  These 20 articles were gathered from Psych INFO, 
EMBASE, and MEDLINE and included articles from first date available to May 2010.  Most 
interesting to the current study, Ougrin found a statistically significant difference between 
treatments for SP.  CT was more effective than ET in both short term outcomes (Z = 3.72, p = 
0.0002) and long-term outcomes (Z = 3.28, p = 0.001).  Considering the application of trauma 
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informed research and practice in the current study, the results about PTSD outcomes are also 
worth noting.  There were no significant differences between treatment outcomes for PTSD.  A 
correction to this meta-analysis was published by Ebrahim and Bance (2012) finding some 
statistical errors in Ougrin’s analysis.  These authors found a medium effect size for treatment of 
SP with CT and a modest effect size for ET.  Cohen’s d criteria used for assessment of effect 
sizes were: a) 0.2 is a small effect, b) 0.5 is a medium effect, and c) 0.8 is a large effect.  
Ebrahim and Bance concluded, however, that their assessment did not greatly change the main 
interpretation of Ougrin’s work. 
 Cognitive Behaviour Therapy.  Cognitive therapy is often used in conjunction with 
behaviour therapy in work with anxiety, thus leading to the new umbrella title Cognitive 
Behaviour Therapy (CBT).  CBT uses strategies to help the client become aware of his or her 
behaviours, reactions, and thoughts.  The focus is upon changing problematic thinking and 
behaviour patterns (Sheldon, 2011).  Psychoeducation is used to help clients become aware of 
why their specific issues occur and to help them understand how CBT works.  The importance of 
psychoeducation is to draw clients’ awareness to how their thoughts, behaviours, and emotions 
interact (Friedberg & McClure, 2002).  Skill building may be used to help the client identify their 
unhelpful cognitions and learn to challenge those cognitions to make more positive and accurate 
assessments in their everyday lives (Miller, Short, Garland, & Clark, 2010).  Relaxation training 
is often implemented to help individuals cope with peaks in anxiety (or other symptoms; Barrett, 
Lowry-Webster, & Turner, 2000).  CBT is also used with exposure therapy to help clients face 
their anxieties (Craske & Barlow, 2007).  This combination of cognitive and behavioural 
interventions is intended to help clients learn to manage their thoughts and behaviours, so they 
gain more stability and control over their emotions.  
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 CBT is usually a short-term treatment for 10-12 sessions.  Because of the short-term nature 
of the treatment, clients often leave therapy with residual symptoms (Sheldon, 2011).  Clients are 
able to take the tools and techniques learned in therapy into their real life activities.  The goal of 
CBT is to help the client learn techniques to manage their own treatment and therapeutic work 
after they leave formal therapy.  CBT can be done via individual or group therapy sessions.   
 Cognitive Behaviour Group Therapy meta-analysis.  Wersbe, Sijbrandij, and Cuijpers 
(2013) conducted the first meta-analysis to assess the effectiveness of Cognitive Behaviour 
Group Therapy (CBGT) on Social Anxiety Disorder (SAD).  Eleven studies were gathered from 
PubMed, Cochrane, PsychINFO, and Embase.  Every one of these studies were randomized 
controlled studies in which the participants were diagnosed with SAD and given CBGT in 
comparison to a control group.  The authors suggest the overall quality of these studies was 
moderate.  The effect size resulting from the meta-analysis suggested a 0.53 (95% COI: 0.33-
0.73) difference between the CBGT and control conditions in favour of CBGT.  The CBGT 
condition showed a moderate, yet significant, effect in the treatment of SAD in the meta analysis 
even though individual studies had effect sizes ranging from 0 (no effect size) to 1 (a large effect 
size).  The authors reported that heterogeneity of values ranged between low and moderately 
high within all the analyses.  The authors suggest future research be done comparing these group 
therapies for SAD to control conditions.   
 Mindfulness- and Acceptance-Based interventions.  Mindfulness and Acceptance, while 
two different concepts, are often used together.  Mindfulness came from Buddhist tradition while 
acceptance came from Christian teachings (Brown, 1987).  The definitions and theories of these 
concepts are useful to understand more about how these two concepts work individually and can 
be integrated together in psychotherapy.   
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 Being mindful involves self-regulating your attention to the experiences of the present 
moment in a non-judgemental, accepting way (Bishop et al., 2004).   A well known definition of 
mindfulness is “the awareness that emerges through paying attention on purpose, in the present 
moment, and non-judgementally to the unfolding of experience moment to moment” (Kabat-
Zinn, 2003, p. 145).  Mindfulness involves three main aspects (Shapiro et al., 2006): a) intention, 
which is a curiosity into what values motivate the practice of mindfulness; b) attention, actively 
noticing the experiences of the present moment; and c) attitude, which is how one pays attention 
to the present moment.  The main attitudes which should be applied during the attention process 
are: (a) patience, (b) non-judging, (c) openness, (d) non-striving, (e) trust, (f) acceptance, and (g) 
“letting go” (Kabat-Zinn, 1990).  The Buddhist practice of mindfulness also emphasizes 
gentleness, loving-kindness, curiosity, and non-reactivity.  Mindfulness has the potential to help 
regulate stress by calming various physiological systems, by allowing a greater connectedness 
between the mind and body (Schwartz, 1984, 1990).  This connection can increase the ability for 
self-regulation and the ability to restore order to physiological systems, which will improve 
emotional and physical well being.  A mindful way of interacting with the present helps prevent 
in-the-moment concern over future and past.   
 Acceptance is considered a way to reach spiritual freedom, by using acceptance to deal 
with the struggles intrinsic to human life (Brown, 1987).  The practice of acceptance allows you 
to become present and open, to let go of the struggle with painful internal experiences (Brach, 
2004).  It is worth noting this does not mean one should stay in destructive situations but, rather, 
by becoming aware of these situations, one can become more capable of leaving such situations 
(Follette & Hazlett-Stevens, 2016).  Acceptance may help clients to deal with what they may 
become aware of during mindfulness.  
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 Mindfulness Based Interventions: A meta-analysis.  A meta-analysis was conducted on 
the effectiveness of mindfulness-based interventions (MBIs) for treatment of diagnosed Anxiety 
or Depression (Strauss, Cavanagh, Oliver, & Pettman, 2014).  The authors conducted this meta-
analysis because they questioned whether standard MBI practices would be of benefit to those 
who have symptoms meeting diagnostic criteria.  Their main four concerns were that: (a) 
attending to current thoughts and feelings with acceptance may be difficult for those with anxiety 
(Eaves & Rush, 1984; Strauss, Cavanagh, Oliver, & Pettman, 2014); (b) attending to thoughts 
and feelings without perseverating on them could be difficult because of the tendency to 
perseverate on anxious thoughts and feelings (Barnhofer & Crane, 2009; Borkovec, Alcaine, & 
Behar, 2004; Borkovec & Roemer, 1995; McLaughlin & Hoeksema, 2011; Mogg, Bradley, & 
Williams, 1995; Muris, Roelofs, Rassin, Franken, & Mayer, 2005; Nolen-Hoeksema, 2000); (c) 
the concentration and motivational difficulties usually experienced by those struggling with 
anxiety may make mindfulness a difficult state to achieve (Barnhofer et al. 2009; Eysenck, 
Derakshan, Santos, & Calvo, 2007; Haslam, Atkinson, Brown, & Haslam, 2005); (d) brief 
therapy, as is usually the case for MBI, may not be sufficient for treating anxiety.  This meta 
analysis was conducted to discern whether or not the authors’ concerns were supported.  
 Twelve studies on MBIs for anxiety or depression were included with a sample size of 578 
participants.  The best effects were seen for depressive symptoms but not for anxiety symptoms.  
There was not statistically significant improvement for those with confirmed anxiety disorders or 
for anxiety symptoms from the full-range of studies.  The authors suggest professionals be 
careful when using MBIs for clients with anxiety disorders where anxiety symptoms are the 
target.   
 Mindfullness- and Acceptance-Based interventions: Meta-analysis.  Vollestad, Nielsen, 
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and Nielsen (2012) conducted a systematic review and meta-analysis into studies using 
mindfulness- and acceptance-based interventions (MABIs) for participants with Panic Disorder 
(PD), Social Anxiety Disorder (SAD), and Generalized Anxiety Disorder (GAD).  They found 
19 eligible studies and conducted a meta-analysis of within-group pre- to post-treatment effects.  
Their results had Hedges’ g effect sizes of 1.08 and 0.85 for anxiety and depression symptoms, 
respectively.  They went further to assess the controlled studies which yielded a Hedges’ g of 
0.83 for anxiety symptoms and 0.72 for depression symptoms.  They assessed and found no 
significant moderating effects for things such as intervention type, design, treatment dosage, or 
patient.  The authors did note, however, that differing effect sizes warrant adding specific types 
of psychotherapeutic interventions to mindfulness training.  They also found individual therapy 
to be more advantageous than group therapy.  They conclude that MABIs are effective at 
reducing anxiety symptoms and the associated depressive symptoms. 
 A more recent study was conducted looking at mindulness- and acceptance-based 
treatments (MABTs) for Social Anxiety Disorder (SAD) specifically (Norton, Abbott, Norberg, 
& Hunt, 2014).  The authors conducted a systematic review of 9 studies assessing MABTs for 
SAD in PsychoInfo, Medline, PubMed, and Cochrane Central Register of Controlled Trials.  The 
authors of this review found significant improvements in symptoms as a result of treatment with 
MABTs but the benefits were equal to, or less than, the benefits from Cognitive Behavioural 
Therapy (CBT).  The authors of this review note that some of the studies had methodological 
weaknesses and risks of bias, while others were uncontrolled or had small sample sizes.  While 
there are indications that MABTs can reduce SAD symptoms, the outcomes should be accepted 
and applied with caution until future research can be done.   
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Trauma Informed Treatment for Social Anxiety Disorder 
 Thus far, the treatments reviewed in this chapter have included (a) cognitive, (b) 
behavioural, (c) current physiological calming, and (d) acceptance based aspects of SAD.  At 
first glance this seems like a thorough approach to treatment.  There are, however, still aspects 
which may not be addressed by those treatments.   
 Erwin et al. (2006) studied responses to very stressful social situations, of 45 participants 
with Social Anxiety Disorder (SAD).  Those individuals had experiences which did not meet the 
criteria for posttraumatic stress disorder (PTSD) according to the DSM-IV.  The researchers 
were particularly interested in the occurrence of symptoms usually associated with PTSD, such 
as the frequency of avoidance, re-experiencing, and hyperarousal.  Such responses were found to 
be very common.  Over one third of the sample would be diagnosed with PTSD if their traumatic 
events had met the criteria in the DSM-IV.  A total of 94% of those participants reported that 
their symptoms had occurred for more than 3 months.  Results of studies have shown that social 
interaction and public speaking are often associated with elevated systolic blood pressure 
(Turner, Beidel, & Larkin, 1986) and increased heart rate (Ost, Jerremalm, & Johansson, 1981) 
but Erwin et al. (2006) suggested that hyperarousal symptoms, such as those for PTSD Criterion 
D (irritability, sleep difficulties, hypervigilance, concentration difficulties, and exaggerated 
startle response) were the more extensive, and potentially impairing, symptoms.  The authors 
explained the combination of emotional and cognitive avoidance responses to memories of these 
socially traumatic events.  Results of this study suggest that memories of these past traumatic 
events impacted those with SAD as much as current or anticipated future performances or social 
situations.  The vividness of these social memories suggests that they are pervasive, even though 
they are in the past, much like other traumatic memories.  As a result, the authors suggest that 
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treatments for PTSD should be used to treat SAD.  They endorse cognitive-behavioural and 
exposure treatments, but question whether these treatments can access all aspects of fear 
memories.  
Wild et al. (2008) did a study to check the effectiveness of re-scripting early memories of 
unpleasant social experiences.  This was an early study (n = 11), with two sessions given a week 
apart.  The first, a control session, involved discussion of participants’ memories and images 
without modification.  The next was an experimental session, with cognitive restructuring and an 
imagery re-scripting procedure intended to update and conceptualize memories.  No changes 
were found for the control session but the experimental session caused improvements in: (a) 
negative beliefs; (b) fears of negative evaluation; (c) levels of image/memory distress and 
vividness; and (d) social anxiety.  The authors suggested that re-scripting these unpleasant social 
memories (associated with negative self-images) could help in the treatment of social phobias.  
The results of these studies reveal how SAD can have symptoms similar to those associated with 
trauma, and suggest that treatment of those social traumas could be treated successfully with 
trauma therapies. 
 These traumatic ties to anxiety bring a fundamental psychological concept to mind; this 
concept is transference.  Transference is described as the “experience of impulses, feelings, 
fantasies, attitudes, and defenses with respect to a person in the present which do not 
appropriately fit that person but are a repetition of responses originating in regard to significant 
persons of early childhood, unconsciously displaced onto persons in the present” (Greenson & 
Wexler, 1969, p. 28).  These transference experiences can cause substantial difficulty in 
interpersonal relationships (Wolitzky, 2011).  Since past experiences can trigger negative 
transference reactions, individuals with public speaking anxiety may experience such 
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transference reactions with those listening to them speak (i.e., audience members).   
 A study by Wieser, Pauli, Reicherts, and Mühlberger (2010) assessed neurological activity 
in anticipation of a public speech.  The researchers found larger N170 amplitudes on 
electroencephalogram assessments when participants saw angry faces, and smaller N170 
amplitudes when they saw happy or neutral faces.  They used early posterior negativity to check 
for motivated attention, and found motivated attention to be higher when participants viewed 
angry faces as opposed to happy or neutral faces for those in a public speaking group.  They 
concluded that public speaking fears can change the way participants process faces, particularly 
angry faces.  This heightened negative response to angry faces could be an aspect of transference 
associated with disturbing past experiences.   
 Each of these studies contributes possible extensions beyond standard anxiety research 
protocols, including (a) broader traumatic criteria, (b) processing of past traumatic social 
experiences, and (c) negative transference reactions.  These ties to traumatic antecedents of 
anxiety constitute reasons to consider current treatments for trauma and their potential for 
helping those who struggle with performance-specific SAD.   
Current Trauma Treatments  
 A trauma informed approach to treating SAD requires examination of current trauma 
treatment efficacy.  Many treatments are used to treat trauma but few are especially designed to 
work with the underlying sources of traumatic symptoms.  Some of these treatments are: (a) 
Exposure Therapies, (b) EMDR, (c) CBT, and (d) Present-Centered Therapies (PCT).  The 
following literature reviews are meta-analyses of the aforementioned treatments for treating 
trauma.  The first is a review of a complex study comparing trauma treatments to the other types 
of treatments.  Next is a meta-analysis of Trauma Focused Exposure Therapy followed by a 
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meta-analysis examining the effectiveness of EMDR.  Each of these reviews will provide more 
context for the current treatments for trauma.   
 Comparison of treatments used to treat trauma.  Tran and Gregor (2016) conducted a 
meta-analysis comparing several bona fide psychotherapies for treatment of Post-Traumatic 
Stress Disorder (PTSD).  The authors defined “bona fide” treatments as those which met the 
following criteria: (a) administered by a trained therapist who considered the therapeutic 
relationship when adjusting the treatment, (b) administered face-to-face, and (c) satisfying 
criteria provided by the author, as follows.  Treatment descriptions in each study needed to meet 
two of four set criteria: (a) references to the theoretical approach used, (b) description of 
psychological processes, (c) references to treatment manuals, and (d) descriptions and references 
to the active ingredients of the treatments.  The authors conducted this analysis because previous 
analyses had suggested Exposure Therapies (ET), Cognitive Behaviour Therapies (CBT), trauma 
focused Cognitive Behavioural Therpaies (TFCBT), and Eye Movement Desensitization 
Reprocessing (EMDR), are of similar effectiveness while non-trauma focused therapies (i.e. 
hypnotherapy, psychodynamic therapy, or supportive therapy) showed inconsistent results (11-
21).  Eligibility criteria included: (a) randomized controlled trials (RCTs), (b) comparisons of at 
least two bona fide therapies, (c) treatments doses lasting at least two sessions, (d) adult 
participants, (e) PTSD diagnoses based on the DSM criteria at the time of each study (DSM-III 
and DSM-IV for the studies included), and (f) severity of the symptoms assessed with either a 
clinical rating or self-report.  They found 22 randomized control trials with a total of 1,694 
patients.   
 Treatments included in this study included: (a) Exposure Therapies, (b) Prolonged 
Exposure, (c) combined Exposure and Prolonged Exposure Therapies, (d) EMDR, (e) CBT, and 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  23 
(f) Present-Centered Therapies (PCT).  The PCT interventions included such treatments as 
Rogerian client centered work like (a) present-centered, (b) psychoeducative, and (c) problem 
solving.  CBT clinicians were permitted to use, but not to depend on, certain techniques from 
other therapies.  Treatments were coded as (a) trauma-focused (TF), or (b) not-trauma-focused 
(NTF).  TF treatment were required to focus specifically on traumatic event memories and 
subsequent appraisals.   
 Results of the studies were analyzed to see which therapies were most efficacious for 
treatment of PTSD.  Treatments showed similar results in clinical significance and dropout rates.  
The treatments which focused on trauma did show greater efficacy than those which were NTF 
but this result did not quite reach significance (p = .095).  The TF treatments did appear more 
effective when working with PTSD symptom severity at post-treatment, and at first and second 
follow-ups.  Similar efficacy was found for (a) exposure therapies, (b) prolonged exposure, (c) 
CBT, and (d) TFCBT.  The authors did note, however, that these results could be due to low 
quality studies being included in the analysis.  When they excluded the studies which seemed to 
be a low quality the prolonged exposure and exposure therapies showed an advantage in 
treatment of PTSD symptoms at the post-treatment assessment.  The results showed that PCTs 
were slightly less helpful for PTSD symptom severity at the post-treatment and follow-up 
assessments.  These results showed that many of these bona fide treatments had similar efficacy 
but, when studies with a questionable quality were removed, exposure and prolonged exposure 
had a stronger impact on PTSD symptoms.  
 Trauma focused Exposure Therapy.  Modern technology has provided new ways to treat 
Post-Traumatic Stress Disorder (PTSD).  Of these new technological resources, Virtual Reality 
has become very applicable to exposure therapy.  Some meta-analyses have compared the use of 
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traditional exposure therapy and virtual reality exposure therapy.  The following review is a 
meta-analysis to address this comparison.  
 DiMauro (2014) conducted a meta-analysis which compared the effectiveness of traditional 
cognitive-behaviour-based exposure therapy versus virtual reality exposure therapy (VRET) for 
treatment of PTSD.  In this meta-analysis, the authors compared pre- and post-treatment effect 
sizes and interactions across 26 articles.  Article inclusion criteria included: (a) aged at least 18 
years and diagnosed with PTSD, (b) standardized diagnostic measures (e.g., Clinician-
Administered PTSD Scale, Symptom Scale-Interview, or Posttraumatic Diagnostic Scale), (c) 
treatments provided face-to-face (rather than online or over the phone), and (d) distinct treatment 
groups.  Articles were selected from PsychArticles and Psychinfo.  The first set of articles 
included 15 articles on traditional therapies for PTSD and were found using key words of “Post-
traumatic Stress Disorder,” “Posttraumatic Stress Disorder,” or “PTSD,” paired with the words 
“exposure therapy,” “In Vivo exposure,” “prolonged exposure,” “imagined exposure,” and 
“flooding.”  The second set of 6 articles was regarding VRET.  Search words included 
“Posttraumatic Stress Disorder,” “Post-traumatic Stress Disorder,” or “PTSD” along with 
“Virtual Reality.”  The results were insignificant, though showing a trend towards significance (p 
< .05), with findings supporting traditional exposure therapy over VRET.  The authors suggest 
that a larger database of studies may have rendered significant results.  
 Eye Movement Desensitization and Reprocessing.  Davidson and Parker (2001) 
conducted a meta-analysis comparing Eye Movement Desensitization and Reprocessing 
(EMDR) with other therapies.  The researchers collected 34 studies from various databases over 
select years: (a) Medline and PsychINFO from 1988 to April 2000; and (b) Current Contents 
from 1997 to March 2000.  Keywords used in these searches were EMDR and eye movement 
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desensitization and reprocessing.  The focus of this meta-analysis was to compare participants 
across conditions: (a) participants treated with EMDR; (b) participants treated with treatments 
other than EMRR; and (c) participants who did not receive treatment.  They broke these 
conditions down into seven categories with the first being a within-subjects comparison between 
pre-post EMDR assessment scores.  The remaining six categories compared EMDR to: (a) no 
treatment, (b) Cognitive Behaviour Therapy or in vivo exposure, (c) exposure (without in vivo), 
(d) eyes fixed desensitization reprocessing (EFixDR, in which the eye moment aspect of EMDR 
is left out of the EMDR treatment protocol), and (e) other dismantling designs (OthDism, when 
the EMDR protocol was used with the omission of one specific aspect while eye movement was 
used), (f) nonspecific treatments (e.g., biofeedback, active listening, applied relaxation, but no 
therapies in which anxiety provoking stimuli were presented).  The results of analysis showed 
EMDR was effective when: (a) post-treatment EMDR group assessment results were compared 
to pre-treatment EMDR group (within-participant comparisons), and (b) when EMDR post-
treatment measure was compared with untreated controls.  EMDR was not, however, shown to 
be more effective than exposure therapies, EFixDR, or OthDism.  This meta-analysis suggests: 
(a) EMDR is effective in treating trauma but that the exact protocol may be unnecessary; and (b) 
EMDR may not be more effective than other uses of exposure.  
Alternative Treatments Used in This Study 
 Two treatments with different approaches were used in this study to treat performance-
specific SAD.  The first treatment, Observed and Experiential Integration, addressed the 
underlying traumatic experiences of SAD, borrowing from a variety of theories to develop a 
holistic approach.  The second treatment was a grounding and relaxation protocol, known as 
BRAIN, which addressed immediate coping with trauma symptoms present in performance-
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specific SAD.  The logic for using these two types of treatments was to compare the treatment of 
underlying trauma (trauma-root-focused treatment) with the treatment of current trauma 
symptoms (symptom-focused treatment).   
OEI and BRAIN were chosen for this study because they work with the neurobiological 
correlates of anxiety and trauma found in the fight-and-flight response (Porges, 2007).  As seen 
in this literature review, many types of treatment used for anxiety interact with this group of 
symptoms as behavioural or cognitive, which does not necessary draw upon the insights from 
trauma therapy.  OEI and BRAIN interact with deeper level emotional responses and therefore 
work with the body’s natural response to fear (activated by the limbic system) instead of trying to 
work against the natural fear response.  A cognitive or behavioural approach is more likely to try 
to override the natural fear response by struggling to regain cognitive control (reengaging the 
cortex of the brain) without calming the limbic system.  OEI and BRAIN engage with the the 
client based on what their brain is doing in the moment and allow for dissipation of the fear 
response so the cortex is emotionally safe to reengage.  
See Appendix B for a diagram of how the polyvagal theory of fear response occurs and to 
Appendix C and Appendix D to see how OEI and BRAIN interact with this fear response.  It is 
worth noting that it is very hard to act in a cognitive way after the ventral vagal break is off and 
even harder once the freeze response has occurred.  It is even difficult to use the BRAIN 
techniques after the freeze response has occurred but there are several OEI techniques which can 
still be applied at that point.  These diagrams show how these different techniques are able to 
engage with the various stages of fear response.  
Observed and Experiential Integration 
In the previous sections, mainstream treatments for public speaking anxiety were 
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reviewed.  In contrast, this section constitutes a theoretical and technical review of a treatment 
that has never before been used to treat performance-specific SAD in a formal study.  Observed 
and Experiential Integration (OEI) was selected as one of the two treatments used in this study 
because it has been shown to reduce trauma-related anxiety symptoms (Bradshaw, McDonald, 
Grace, Detwiler, & Austin, 2014).  In light of those research findings, it was postulated that OEI 
would also help to process posttraumatic aspects of social anxieties, as mentioned previously 
(Erwin et al., 2006; Wild et al., 2008).  OEI has been used in hundreds of thousands of hours of 
clinical practice over a period of 21 years (R. A. Bradshaw, personal communication, June 15, 
2015).  Within these hours, OEI has been used to successfully treat public speaking anxiety, 
usually in 1-3 sessions.  To follow up these promising clinical observations, this study constitutes 
the first formal investigation of OEI to treat performance-specific SAD, using short term 
treatment (7 sessions).  In this section, the theoretical background and development of OEI are 
outlined.  In addition, OEI techniques are reviewed, along with studies in which OEI has been 
used as a trauma treatment. 
Theoretical background.  OEI is a theoretically integrated treatment.  Gold and Stricker 
(2006) described several types of integration: (a) Assimilative Integration, (b) Technical 
Eclecticism, (c) Common Factors, and (d) Theoretical Integration.  In this section readers will 
also learn how each of these types of integration was used in the development of OEI.   
Furthermore, Bradshaw has compiled a description of OEI through other theoretical 
lenses.  The main theoretical lenses he has summarized are combinations of 
Behavioural/Neurobiological and Psychoanalytic/Psychodynamic.  Many treatments are 
presented through their own theoretical lenses with little regard to what they are missing from 
other ways of approaching the presenting problem.  In this summary, Bradshaw explains how 
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OEI addresses many of the mechanisms of change described by Behavioural, Neurobiological, 
Psychoanalytic, and Psychodynamic theorists.  OEI encompasses most of the mechanisms 
inherent in therapies discussed earlier in this document.  This summary can be seen in Appendix 
E.  
 Assimilative integration.  At the heart of OEI is Experiential Psychotherapy (Bradshaw et 
al., 2011).  This aspect is closely related to Accelerated Experiential Dynamic Psychotherapy 
(Fosha, 2002).  The Therapist is constantly tuning into clients’ expressions on a second-by-
second basis, while giving them directives according to OEI theory.  The client is also practicing 
Focusing (Gendlin, 1984), by paying attention to slight affective and somatic states and shifts, 
while following the therapist’s directions.  Focusing is at the foundation of OEI, from an 
experiential perspective.  
 Relational Psychoanalytic Therapy is then applied, as each therapist interacts with micro-
level expressions of clients, which are contingent on eye movements and facial expressions 
clients have during treatment.  This micro-level process is combined with empathic reflections 
from therapists, across sessions.  As these comments coincide with experiences of clients, each 
therapist is able to join with his or her client and build relationships of understanding (Bradshaw 
et al., 2011).  
 Negative reactions to the faces of therapists were noted during the development of OEI 
Switching (i.e., alternate left and right monocular covering).  This reaction constitutes negative 
transference.  Distortions clear as clients “switch” (Bradshaw et al., 2011). 
 There are some similarities in the neurobiological aspects of OEI and Schiffer’s Dual Brain 
Psychology (Schiffer, 1998).  He noticed differences in emotional states when light was blocked 
from both eyes with the exception of the right or left lateral visual fields.  He described these 
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shifts as either “irrational” (similar to the id) or “rational” (similar to the ego).  Similarly, OEI 
involves alternate monocular covering.  This technique, in combination with several others 
described in the OEI Techniques section of this document, “neurologically activates, dissipates, 
and shifts perceptions through repeated applications” (Bradshaw et al., 2011, p. 111). 
Technical eclecticism.  Some techniques were integrated without adoption of underlying 
theories.  One of these techniques, guided eye movements and bilateral stimulation (both 
auditory and tactile) resulted in Glitch Massaging techniques (Bradshaw et al., 2011).  Another 
technique borrowed without theoretical acceptance is ‘lazy eights’ from Educational Kinesiology 
(Brain Gym; Dennison & Dennison, 1986, 1994).  This technique was adapted, to become the 
OEI technique known as “Sweeping”, which is only used for resolving somatic symptoms such 
as drowsiness, headaches, tingling, dizziness, numbing, and visual disturbances (Bradshaw et al., 
2011).  A third technique involves use of a balance board, to help counteract loss of balance 
associated with dissociation, by providing instant feedback to clients that they are “tuning out”. 
Common factors approach.  Common factors across many effective psychotherapies are 
incorporated into OEI, which contribute to the effectiveness of this treatment.  These include: 
empathic attunement, insight, self-awareness, and hope.  The most important of these factors is 
empathic attunement.  In agreement with Greenberg (2008), OEI therapists believe the use of 
emotion is also very important.  OEI involves use of empirically-supported, emotion-focused 
change processes.  All five of Greenberg’s principles of change in the affective domain are 
incorporated in OEI: “Increasing emotional awareness, facilitating emotional expression, 
improving emotion regulation, promoting greater reflection on emotion, and transforming 
emotion with the activation or presentation of alternate emotion(s)” (Bradshaw et al., 2011, p. 
115). 
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Theoretical integration.  When a trauma response is triggered, blood flow to the left 
dorsolateral prefrontal cortex is reduced, causing difficulty in coherent and clear speech (Rauch 
et al., 1996).  Other symptoms of trauma, such as dissociative experiences, panic attacks, and 
flashbacks, are not accessed easily through words because they emanate from subcortical areas 
of the brain (limbic and paralimbic regions; see van der Kolk, 2002).  Along with these 
neurobiological principles, other theoretical mechanisms have been included in OEI to address 
neurobiological and behavioural aspects of clients’ experiences. 
Neuro-activation and microattunement during trauma processing.  During OEI 
treatment, mirror neurons are activated in therapists and they experience the emotions of their 
clients to a limited extent (known as “embodied simulation”).  Gallese, Eagle, and Migone 
(2007) suggest that this experience helps clients to see their emotions in the faces of their 
therapists and, in turn, to “experience the modulation and containment of such states” (p. 160).  
If therapists notice and comment on the slightest movements in the eyes and facial expressions of 
clients while they are experiencing emotional changes, those clients will feel more connected 
with their therapists.  This attunement helps each client develop secure attachment with his or her 
therapist. 
Classical Conditioning of sensory, emotional, and cognitive responses.  Classical 
conditioning can occur with sensory stimuli such as sights, smells, somatic sensations, tastes, and 
sounds to amygdalar and hypothalamic-pituitary-adrenal (HPA) axis activation (van der Kolk, 
2001; Yehuda, 1997, 2002).  People are triggered by both external discriminative stimuli, and 
internal cues like racing heartbeat, shortness of breath, and lightheadedness caused by 
amygdaloid arousal (Barlow, Allen, & Basden, 2007).  OEI does not rely exclusively (or even 
primarily) on exposure to extinction.  Treatment involves having clients use the OEI technique of 
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Switching, during which they expose the eye associated with the most somatoaffective intensity 
to light, for one to five seconds (to as short a duration as half a second in extremely intense 
cases).  By these means, intensity can be dissipated by Switching (alternately covering the eyes).  
Neuro-activation and microattunement (NAMA) are considered the primary processes of change 
in OEI (Bradshaw et al., 2014). 
 Incorporation of polyvagal theory.  All three levels of human response (according to 
polyvagal theory; Porges, 2007) are addressed in OEI (Bradshaw et al., 2011).  According to this 
theory, humans respond in a hierarchy of three levels of neurobiological activation.  The top 
level (referred to as “Social Engagement”) involves the ventral vagal complex when it is not 
adrenalized (i.e., when the “brake” is “on”).  In this state, the larynx, pharynx, bronchi, lungs, 
esophagus, and heart) are relaxed.  The next level of response involves activation of the 
sympathetic branch of the autonomic nervous system (also known as the “fight or flight” 
response).  When the ventral vagal “brake” is “off”, these structures are adrenalized.  Finally, in 
the third level of response, if the “fight or flight” response cannot sufficiently dissipate a threat, 
the Dorsal Vagal Complex (“freeze” response) is activated.  This involves organs below the 
diaphragm (e.g., stomach and intestines) but also restricts bronchi, lungs, and airway, and slows 
the heart.  This final response is often triggered by hypoxia or perceived lack of oxygen.  
Porges (2007) describes implications of polyvagal theory for psychotherapy.  This theory 
is relevant for clinical practice with OEI.  He posits that, in order to shift clients from defensive 
responses (e.g., dorsal vagal and ventral vagal “brake off” states) back to the relaxed state of 
social engagement (ventral vagal, “brake on”), the nervous system must (a) assess risk, and (b) 
inhibit primal limbic system structures which manage fight, flight, and freeze behaviours.  In 
individuals with extensive histories of psychological trauma (abuse and neglect), threat is over-
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generalized.  By this means, their neuroception (unconscious assessment of safety or threat) is 
distorted.  During the neuroception process, feature detectors within the temporal cortex are 
activated (which recognize familiar faces, voices, and hand movements).  Depending on these 
assessments, limbic activity is either enhanced (threat) or suppressed (safety).  In most cases, the 
nervous system is able to evaluate risk (neuroception) and causes appropriate neurophysiological 
responses for the context.  Safe situations result in relaxed limbic structures, allowing calm states 
and social engagement.  If, however, the environment is mismatched with nervous system 
appraisals, individuals may engage in fight, flight, or freeze responses, making social 
engagement and communication extremely difficult.  There are OEI techniques to address all 
three levels postulated in polyvagal theory, and distorted perceptions can be corrected with OEI. 
Coactivation of sympathetic and parasympathetic responses, and tonic immobility.  
Rothschild (2006) recognized polyvagal theory but suggested that the “freeze” response 
triggered during trauma processing was more likely due to coactivation of sympathetic and 
parasympathetic branches of the autonomic nervous system.  She posited that coactivation could 
explain why some clients experience hyperarousal and numbing at the same time.  OEI treatment 
permits clients to achieve release from such states, not only in sessions but between sessions. 
 Ocular proprioception, multisensory memory, and stimulated psychophysiological 
schemas.  Intricate information about the movements and locations of the eyes, relaxation or 
constriction of the intraocular muscles, and positions of the eyelids is sent to the brain by large 
numbers of proprioceptive neutrons in extra- and intra-ocular muscles (Batini, Buisseret, 
Lasserre, & Toupet, 1985; Donaldson, 2000; Dutton, 2003).  Specialized ocular muscle 
components (“multiply innervated muscle fibers”) have palisade endings, implying they employ 
proprioception to control slow, gradual movements and contractions (Buttner-Ennever, 2006, 
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2008).  The Glitch Massage technique in OEI involves noting the types and speeds of eye 
responses (Bradshaw et al., 2011).  There are several intra-ocular muscles: those which control 
the thickness and curvature of the lenses, and those which dilate and constrict the pupils 
(Buttner-Ennever, 2006, 2008).  The last group of muscles involved are the extra-ocular muscles 
which move the eyelids, known as levator palpebrae superioris.  All of these muscles and 
neurons work together to make movement-related associations.   
 According to OEI theory, specific movement patterns and distances (of objects) from the 
eyes, and resultant eye movement and lens focusing, can become classically conditioned to 
specific amygdalar states and HPA axis arousal (Bradshaw et al., 2011).  Specific eye positions 
can be accessed while clients relive (i.e., somatoaffectively recall) events with which they are 
associated.  This can be done intentionally, using multisensory imaginal visualization.  By 
guiding a client’s eye(s) into and through points which have been conditioned to traumatic 
events, symptoms of intensity or numbing can be dissolved.  Often, simply having a client cover 
his or her dominant eye can reduce intensity (or at least change the emotion) and this difference 
is profound and observable enough to engage the client in the process.  
 Observed and Experiential Integration techniques.  In this section the five main 
techniques of OEI will be described (Bradshaw et al., 2011).  The main techniques are: (a) 
Switching, (b) Tracking and Massaging glitches, (c) Sweeping, (d) Glitch Holding with Bilateral 
Stimulation, and (e) Release Points.  
 Switching.  Switching involves alternate monocular covering of the left and right eyes 
while thinking of distressing memories or disturbing symptoms.  This technique can be used for 
(a) titrating intensity associated with traumas, (b) reducing dissociative artefacts (e.g., loss of 
balance, dizziness, drowsiness, visual distortions, or headaches), and (c) detecting and resolving 
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negative transference reactions. 
Tracking for glitches and Glitch Massaging.  While tracking for glitches, clients think 
about traumatic memories or disturbing symptoms and track a stimulus (such as a therapist’s 
fingers) across one or both visual fields.  When hesitations, blinking, or skipping (i.e., “glitches”) 
are seen in eye movements, the therapist “massages” them by guiding one or both eyes back and 
forth or toward and away from the eyes until they move smoothly and emotions are dissipated. 
Sweeping.  The Sweeping technique is a combination of Switching and Tracking, used to 
reduce dissociative artefacts (headaches, visual distortions or occlusions, drowsiness, etc.).  
Glitch Holding with Bilateral Stimulation.  Glitch Holding with Bilateral Stimulation is 
useful for resolving “visual splitting” (i.e., when one eye seems focused on a stimulus while the 
other “wanders”).  The therapist holds the client’s eyes in the “glitch” (usually in the upper 
visual fields) while the client engages in rapid alternate tapping of his or her left and right 
shoulders. 
Release points.  Knowing that there was a “most intense point” in the “most intense” eye 
(i.e., a glitch in the dominant eye), Bradshaw looked for (and found) the “least intense point” in 
the “least intense” (non-dominant) eye: a “peaceful spot” in the non-dominant visual field.  
These points have now been identified, and are used to help release core trauma symptoms such 
as throat constriction, nausea, and bronchoconstriction. 
Observed and Experiential Integration research.  Bradshaw et al. (2017) completed an 
18-month randomized clinical trial with 25 female sexual assault survivors who had developed 
posttraumatic stress disorder (PTSD).  Three treatments were used: (a) Cognitive Processing 
Therapy (CPT-R), a therapy involving cognitive restructuring and behavioural exposure; (b) 
OEI; and (c) a control treatment comprised of calming and grounding techniques, known by the 
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acronym BRAIN (Breathing, Relaxation, Autogenics, Imagery, and grouNding).  Several types 
of measurements were used at pre-treatment, post-treatment, 3-month follow-up, 6-month 
follow-up and final time periods: (a) quantitative, (b) qualitative, and (c) psychophysiological 
assessments.  Assessors were blind to group assignments (treatment conditions), and participants 
were randomly assigned to one of the three groups.  All three groups showed significant 
reductions in PTSD symptom severity between pre-treatment and post-treatment assessments.  
Significant differences between the groups were found at the 3-month follow-up, at which time, 
OEI was more effective than BRAIN.  All groups showed increases in PTSD symptoms at the 6-
month follow-up, likely a result of having no treatment for 6 months, other than calming and 
grounding techniques.  There was then a cross-over for a second round of treatments.  Once 
again, significant improvements were found equally among the groups.  At the final assessment, 
75% of the participants reported that OEI was most effective for reducing their PTSD symptoms.  
In addition, many participants reported that CPT was helpful for reducing self-blame, shame, and 
guilt.  The authors surmised that OEI was at least as helpful as CPT, and that all three treatments 
were effective for treating PTSD symptoms. 
Bradshaw, McDonald, Grace, Detwiler, and Austin (2014) conducted a pilot study 
comparing OEI to a delayed treatment control.  The Clinician-Administered PTSD Scale (CAPS) 
and the Impact of Event Scale-Revised (IES-R) were used as dependent measures.  Script-driven 
symptom provocation was used to activate symptoms for assessment purposes.  Ten participants 
diagnosed with PTSD (3 male, 7 female) received three 1-hour sessions of OEI “Switching”.  
Participants in the OEI treatment group showed greater improvement than those in the control 
group in terms of reduction of PTSD symptoms.  The delayed treatment group later received the 
same treatment.  Nine of the ten participants no longer met the criteria for PTSD at the end of the 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  36 
study.  This RCT portion of this study was later supplemented by a qualitative 2-year follow up.  
The follow-up included 8 of the 10 original participants and all participants reported that OEI 
treatment was important in their paths to recovery.  Several participants clearly described details 
of how OEI helped their individual recoveries.  
BRAIN 
 BRAIN (Breathing, Relaxation, Autogenics, Imagery, and grouNding) was the alternative 
treatment used in this study because relaxation techniques have been found to be helpful for 
coping with trauma symptoms (Taylor et al., 2003), even though previous research findings have 
not indicated major impact of relaxation techniques on SAD with the performance only specifier 
(Alstrom et al., 1984; Wolpe, 1995).  Much of the research on relaxation and PSA did not 
involve either mindfulness or grounding techniques.  BRAIN protocol was chosen to represent 
relaxation and grounding treatments because this collection of techniques is particularly robust 
and has been found to be effective for reducing posttraumatic stress symptoms (Bradshaw et al., 
2017).  The range of procedures included in BRAIN address both physiological and cognitive 
aspects of psychological trauma.   
BRAIN techniques.  Descriptions of the main techniques in the BRAIN protocol are 
provided in the following sections.  The techniques (which are represented by the acronym 
BRAIN) are: Breathing, Relaxation, Autogenics, Imagery, and grouNding. 
Diaphragmatic breathing.  “Belly breathing” shifts respiration out of the chest to the 
diaphragm and the abdominal muscles, thereby deepening and lengthening the breath.  This 
prevents hyperventilation, shortness of breath, breath-holding, and fainting.  Participants are 
instructed to: (a) place one hand on their abdomens and the other on their chests, (b) close their 
eyes and breath in through their noses, and (c) notice how much more their abdominal hands rise 
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than their chest hands.  Participants do this for 5-10 minutes at a time.  “Sighing” when exhaling 
increases relaxation.  Self-statements such as “Breath in relaxation” and “Breath out tension” 
while inhaling and exhaling facilitate deeper states of relaxation.  The diaphragm creates a 
vacuum in the lungs, pulling in more oxygen than thoracic breathing that involves raising the 
shoulders and expanding the ribcage.  
Progressive muscular relaxation.  Muscle tension increases in response to traumatic 
experiences.  Such tension can be triggered situationally or remain more constant.  Increased 
awareness of the difference between relaxed and tense muscles helps participants recognize 
when they are becoming distressed and need to apply relaxation techniques.  Progressive 
muscular relaxation involves guiding participants through major muscle groups, requiring them 
to tense muscles for 5-7 seconds, and then release the tension for 20-30 seconds (only the 
relaxation component is used once participants can differentiate tense from relaxed muscles.  
Major muscle groups include: (a) hands, forearms, and biceps; (b) head, face, throat, and 
shoulders; (c) chest, stomach, and lower back; and (d) thighs, buttocks, calves, and feet.  These 
techniques require practice to consistently reduce muscle tension, and pair relaxation with 
exhalation.  
Autogenics.  This set of mental suggestions helps participants relax their bodies, by 
activating the parasympathetic division of the autonomic nervous system (ANS).  The ANS 
controls smooth muscles, which include internal organs, arteries, veins, and capillaries.  The 
sympathetic branch of the ANS becomes more active after traumatic experiences, to maintain 
vigilance (i.e., the “fight or flight” response).  Autogenics activates the opposite branch (i.e., the 
parasympathetic or “relaxation” division) of the ANS.  
Autogenics involve slow, relaxed, respiratory-synchronized self-talk.  The five statements 
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are: (a) “My breathing is deep and slow”, (b) “My heartbeat is slow and regular”, (c) “My hands 
and arms are warm and heavy”, (d) “My feet and legs are warm and heavy”, and (e) “My 
forehead is cool and dry”.  This self-talk activates vasodilation (i.e., expansion of blood vessels), 
in the extremities, making hands, arms, feet, and legs feel warm and heavy.   
Imagery.  Positive multisensory moving imagery helps participants to replace distressing 
images in their minds with calming pictures.  This involves vividly recalling relaxing, safe 
places, usually in nature (e.g., a tropical beach, garden, lake, river, forest, mountain, or country 
road).  Many find it helpful to imagine protection around the setting to keep it safe (e.g., high 
rock cliffs, a patrolling lion, a large Plexiglas dome, etc.).  Such imagery is combined with 
abdominal breathing, progressive muscular relaxation, and autogenics.  Typical prompts include 
statements that encourage participants to engage their sensory memories, such as: (a) “Notice 
what you see…”; (b) “What do you hear…”, (c) “Pay attention to what you feel in your body…”, 
(d) “Become aware of what you smell…”, and (e) “Imagine your favourite taste…”.  The easiest 
combination of techniques to practice together is imagery with autogenics: “As each wave rolls 
in on the shore, it is perfectly timed with your breathing (exhaling).  The sun warms your hands 
and arms, feet and legs; Your hands and arms are so warm, and so heavy.  There is a gentle 
breeze with a beautiful fragrance, blowing over your forehead and through your hair; Your 
forehead is cool and dry…” 
Grounding.  Grounding helps to reconnect participants to their immediate experiences 
(rather than regretting the past or fearing the future).  Those with past traumas often focus on 
past concerns, and worries about the future.  The goal of grounding is to help clients be more in-
the-moment.  This practice should be applied several times a day.  There are several ways to 
increase grounding, described in the following paragraphs.  These techniques include: (a) sensate 
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focus, (b) Cook’s Hookups, and (c) Cross Crawl.  
Sensate focus.  During this exercise, participants become more aware of their senses.  
Focusing on them, one at a time, increases their ability to therapeutically dissociate from anxiety-
inducing past or future events.  These exercises should be done for 12-15 minutes a day to allow 
sufficient time for participants to tune in to their bodies, one sense at a time.  
 Hearing – Participants are guided to focus on sounds in the room.  They may be 
encouraged to close their eyes or look down at the floor, and focus only on what they hear.  The 
goal is to note what is happening in the moment and not worry about the future or the past.  
Seeing – Participants are guided to notice what they can see around the room (or in 
nature, if they are outside).  The instruction is to find and focus upon colours, objects, pictures, 
or people that are most comforting.  
Touching – Participants are encouraged to touch different textures near to where they are 
sitting or standing, to draw their attention to the current moment.  Noticing the comfort of a chair 
cushion, the coolness of a metal table, or the firmness of the ground can provide distraction at the 
least, and comfort (fur, feathers, fabric) at best.  
Tasting – Most participants find that this sense is helpful for distracting them from states 
of distress.  Carrying and using gum, favourite candies, or snacks when anxious, facilitates 
therapeutic dissociation.  Participants are instructed to take several minutes to notice various 
aspects of taste and texture, to draw their attention away from distressing thoughts or emotions.  
Smelling – This sense is closely associated with emotions due to the anatomical 
proximity of the olfactory bulbs (projecting back from the nose) to the left and right amygdalae 
(in the limbic system, within the midbrain).  This is why smells facilitate immediate recall of 
emotions (both negative “triggers”, and positive “reminders”).  Participants are encouraged to 
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take note of what smells prompt calm, peaceful, or positively energizing emotions.  Typically, 
scented oils come in four broad categories: florals, woods, spices, and citrus fragrances.   
Cook’s Hookups.  The left brain hemisphere controls the right side of the body, and the 
right brain hemisphere controls the left side of the body.  This fact is the basis for two additional 
grounding techniques that are included in the BRAIN protocol.  A left-right imbalance in 
affective arousal can causes numb (“stuck”) or aroused (“stirred up”) states.  These exercises 
involve crossing the arms and legs.  In Cooks Hookups, participants are instructed to sit in chairs 
with their legs crossed (one perpendicular to the other, resting the top leg across the lower thigh 
of the other one).  At the same time, they are instructed to cross their arms just above the wrist 
(and rest their hands on the top leg at mid-calf).   
Cross-crawl.  Participants are instructed to touch their left hands (or elbows) to their right 
calves (or knees), and then repeat the process on the other side, while standing or sitting (lifting 
knees when standing).  This facilitates hemispheric integration, and tactile reconnection to the 
present moment.  When participants dissociate they lose connections to body awareness in space, 
losing their balance.  During cross-crawl, participants are forced to stay connected while 
balancing on one leg at a time (alternating sides).  In addition, the elements of touch and sound 
that occur when hands contact legs facilitate in-the-moment body awareness.   
Relaxation Treatment research.  Taylor et al. (2003) conducted a study comparing 
Exposure Therapy, Eye Movement Desensitization and Reprocessing (EMDR), and Relaxation 
Treatment to treat posttraumatic stress disorder (PTSD).  These treatments resulted in similar 
outcomes in terms of: (a) symptom reduction, (b) symptom severity, and (c) impact on 
hyperarousal or numbing symptoms.  Relaxation and Exposure therapies showed stronger results 
than EMDR as evidenced by: (a) larger reductions in re-experiencing and avoidance, (b) faster 
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improvements, and (c) greater numbers of participants who no longer met the diagnostic criteria 
for PTSD.  In addition, in a study of women with PTSD as a result of sexual assault(s), 
Bradshaw et al. (2017) reported that administration of the BRAIN protocol resulted in equivalent 
reductions in PTSD symptoms to OEI and Cognitive Processing Therapy (CPT-R) from Pre- to 
Post-Treatment assessments (although results for BRAIN faded by the 3-month follow-up, while 
results for OEI and CPT-R were not only sustained but improved).  In light of these positive 
findings regarding application of BRAIN (or other Relaxation Skill Treatment) protocol, this 
collection of techniques was chosen as the alternative treatment for the present study.  It was 
hoped that the BRAIN protocol would reduce SAD social trauma symptoms as well. 
Summary 
 Performance-specific SAD is very common and can disrupt the desired futures of those 
who struggle with this specific phobia.  Many treatments have been used but few of those treat 
psychophysiological hyperarousal caused by past traumatic social experiences.  The treatments 
applied in this study address the commonly missed aspect of trauma in anxiety.  BRAIN focuses 
on the surface trauma symptoms and OEI addresses the root of the trauma.  Using a trauma-root-
focused treatment along side a trauma-symptom-focused treatment provided information on how 
such different trauma treatments impact social anxiety.   
Rationale 
The purpose of this study is to see what type of measurements show changes in 
performance-specific SAD symptoms as a result of trauma based treatments.  Several types of 
treatment are regularly used to treat SAD but these may well neglect the potential traumatic root 
of the disorder.  Two types of trauma treatments were chosen for this study: (a) OEI, to treat the 
traumatic root of the anxiety; and (b) BRAIN, to treat the traumatic symptoms of the anxiety.  
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Different dimensions of assessment are required to understand the full impact of trauma 
treatments on the trauma based symptoms of performance-specific SAD.  The dimensions of 
assessment chosen for this study were based on the (a) emotional, (b) behavioural, and (c) 
psychophysiological symptoms of SAD.  The three measurement categories selected were: (a) 
self report, (b) behavioural, and (c) psychophysiological.  Results of this study provided 
information about the utility of these measures to assess traumatic symptom changes due to 
trauma treatment for performance-specific SAD. 
Research Questions   
The purpose of this project was to develop innovative assessment protocols for clinical 
research on performance-specific SAD.  The initial step was to conduct an investigation of OEI 
(a trauma-root-focused therapy) and BRAIN (a trauma-symptom-focused therapy) on 
performance-specific SAD.  This was a pilot test to explore the assessment and treatment 
protocols as they related to specificity and sensitivity of measures.  The purpose of this study 
leads to the following questions: 
1)   Which groups of measures (self-report, behavioural, or psychophysiological) display 
large effect sizes in response to treatment (sensitivity)?  
2)   Which group of measures show sensitivity across time?  
3)   Which groups of measures (self-report, behavioural, or psychophysiological) display 
different patterns of effect when compared between the treatment groups (specificity)? 
These research questions will allow for evaluation of the research protocols used in this 
project.  The viability of these research protocols can be further demonstrated in future research, 
in which hypotheses associated with specific clinical interventions are explored. 
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CHATPER 3: METHODS 
Participants   
There were 9 participants in this pilot study.  Original recruitment resulted in 14 
participants but 4 dropped out for personal reasons early in the study (2 before treatment started 
and 2 shortly after treatments started).  This left 10 participants, one of whom fell well behind in 
her treatment schedule, as a result of family relocations associated with contract work, and 
eventually was withdrawn from the study.  Effect size results for potential confounding 
background factors were small when compared to the effect sizes of the observed treatment 
effects.  The background variables examined to explore comparability of groups were: sex, 
gender, age, ethnicity, culture, religious affiliation, level of education, and occupation.  The form 
used to gather background information can be seen in Appendix F.  The pattern of background 
factors cannot be described for each participant without compromising the anonymity of 
participants but a general description of the participants included in this study is as follows: (a) 
six cisgender females and three cisgender males; (b) six participants were Caucasian, two were 
East Indian, and one identified as biracial; (c) one participant completed grade 10, one 
participant had completed high-school/GED, three participants had some post-secondary 
education, and four participants had some level of graduate education.  
A small sample size allows for detailed examination of key features of this clinical 
research protocol.  While a small sample does not provide statistical power, this pilot study 
design allows for descriptive examination for selection of treatments and measures for future 
research.  Physiological assessment frequently involves small sample sizes due to response 
demands on participants and intensive demands on research team members.  
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Instruments    
Measures were used at (a) Intake, (b) Pre-Treatment, and (c) Post-Treatment stages of the 
study.  Measures used to screen participants at Intake will be described first, followed by 
instruments used at Pre- and Post-Treatment stages.  Finally, Supplementary measures used to 
monitor participant anxiety and depression will be described.  Together, this collection of 
assessments provides a rich database for each participant.   
Intake assessments.  Intake measures were chosen to screen for participant suitability.  
Since the study involved only short term treatment (7 sessions), participants were assessed for 
severe and comorbid disorders.  Applicants were chosen for the study if their intake assessment 
scores did not reflect comorbid disorders, or conditions more severe than performance-specific 
SAD.  Short term treatment was considered more appropriate for less severe conditions.  Intake 
was also used to determine whether or not self-reported PSA was present sufficiently to justify 
entrance to the study.  Measures used at intake included: (a) Severity Measure for Social Anxiety 
Disorder (Social Phobia) – Adult; (b) Severity Measure for Generalized Anxiety Disorder – 
Adult; (c) Severity of Posttraumatic Stress Symptoms – Adult; (d) Beck Depression Inventory II; 
(e) Dissociative Experiences Scale; and (f) Personal Report of Confidence as a Speaker.  These 
assessments and their cut-off points are described in the following section.  
Severity Measure for Social Anxiety Disorder (SMSAD; Social Phobia) - Adult.  This 
measure consists of 10 items to assess (screen for) severity of social anxiety (phobia) in adults, 
over the previous 7 days (American Psychiatric Association, 2015a).  The measure was designed 
for screening and follow up (i.e., to assess the status of previously-diagnosed social anxiety). 
Items involve ratings on 5-point scales, with: (a) 0 = never, (b) 1 = occasionally, (c) 2 = half of 
the time, (d) 3 = most of the time, and (e) all of the time.  Scores can range from 0 to 40: Higher 
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scores reflect more severe social anxiety.  The total score is then reduced to an average item 
score by dividing the raw total score by the number of items.  This allows severity to be 
expressed on a 5-point scale: (a) 0 = none, (b) 1 = mild, (c) 2 = moderate, (d) 3 = severe, or (e) 4 
= extreme.  During DSM-5 field trials these measures were found to be reliable.  The total score 
is not calculated if 3 or more items are not answered.  If only 1 or 2 items are unanswered a 
prorated score is calculated, dividing the total score by the number of items answered.  The 
Cronbach alpha coefficient was used to assess internal consistency.  In the current study, the 
Cronbach alpha coefficient for this measure was .90.   
To be included in this study participants needed to score below a 2.  If they scored 2 or 
higher, their file was reviewed by Dr. Richard Bradshaw (a registered psychologist with 35 years 
of experience) to decide whether results of the full battery of assessments indicated that 
applicants would be good candidates for the study.   
Severity Measure for Generalized Anxiety Disorder (SMGAD) - Adult.  This measure 
consisted of 10 items to assess severity of Generalized Anxiety Disorder (GAD) in adults during 
the previous 7 days (American Psychiatric Association, 2015b).  Like the Social Anxiety 
screening measure described above, this instrument was designed for screening and follow up 
(i.e., to assess the status of GAD symptoms before and after clinical treatment).  
Items constitute 5-point scales, with: (a) 0 = never, (b) 1 = occasionally, (c) 2 = half of 
the time, (d) 3 = most of the time, or (e) all of the time (American Psychiatric Association, 
2015a).  Scores can range from 0 to 40: Higher scores reflecting more severe generalized 
anxiety.  The total score is then reduced to an average item score by dividing the raw total score 
by the number of items.  This allows severity to be expressed on a 5-point scale as: (a) 0 = none, 
(b) 1 = mild, (c) 2 = moderate, (d) 3 = severe, or (e) 4 = extreme.  This instrument was found to 
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be reliable in DSM-5 field trials.  Total score should not be calculated if 3 or more items are not 
answered.  If only 1 or 2 items are unanswered a prorated score is calculated by dividing the total 
score by the number of items which were answered.  Cronbach’s alpha coefficient was used to 
assess internal consistency in the current study, resulting in a coefficient of .73.  
To be included in this study participants needed to score below 2.  If they scored 2 or 
higher, their file was reviewed by Dr. Bradshaw to decide whether results of the full battery of 
measures indicated they constituted good candidates for the study.   
Severity Measure for Posttraumatic Stress Symptoms (SMPSS-A) – Adult.  This 
measure consists of 9 items to assess for the severity of Posttraumatic Stress in adults during the 
previous 7 days (American Psychiatric Association, 2015c).  Like the Social Anxiety and 
General Anxiety measures described above, this was designed for screening and follow up (i.e., 
to assess the status of PTSD symptoms before and after clinical treatment).  
Items constitute 5-point scales, with: (a) 0 = not at all, (b) 1 = a little bit, (c) 2 = 
moderately, (d) 3 = quite a bit, or (e) extremely (American Psychiatric Association, 2015c).  
Total scores can range from 0 to 36: Higher scores indicating greater severity of Posttraumatic 
Stress.  The total score is then reduced to an average item score by dividing the raw total score 
by the number of items.  This allows severity to be expressed on a 5-point scale as: (a) 0 = none, 
(b) 1 = mild, (c) 2 = moderate, (d) 3 = severe, or (e) 4 = extreme.  This measure was found to be 
reliable in DSM-5 field trials.  The total score should not be calculated if 3 or more items are not 
answered.  If only 1 or 2 items are unanswered a prorated score can be calculated by dividing the 
total score by the number of items which were answered.  Cronbach’s alpha coefficient was used 
to assess internal consistency and in the current study, this coefficient was .79. 
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To be included in this study participants needed to score below 2.  If they scored 2 or 
higher, their file was reviewed by Dr. Bradshaw to decide whether results of the full battery of 
measures showed them to be good candidates for the study.  
Beck Depression Inventory II.  Due to high rates of comorbidity between anxiety and 
depression (Beck, Steer, & Brown, 1996) the Beck Depression Inventory II (BDI-II) was used to 
screen for respondents with high levels of depression (or suicidal risk).  Those with moderate or 
high scores (levels of depression) on the BDI-II were not included in the study.  Referrals to 
counselling services were available for those who may have been at risk of suicide (assessment 
as outlined in the BDI manual; no candidates were found to be suicidal) and for respondents who 
reported “moderate” (or higher) depressive symptoms on the BDI-II.  
The BDI-II is comprised of 21 items, which respondents ranked on 0-3 scales (Beck et 
al., 1996).  Ordinal scale interpretations are: (a) 0 = no more than usual, (b) 1 = more than usual, 
(c) 2 = much more than usual, or (d) 3 = all the time.  A total score of: (a) 0-9 is considered 
“minimal” depression, (b) 10-19 is considered “mild” depression, (c) 20-29 is considered 
“moderate depression, and (d) 30-63 is considered “severe”.  While these scores suggest levels 
of depression, it is important to note that the BDI-II is not a diagnostic tool, but rather a reference 
point for the current experience of depressed mood.  A clinical assessment by a qualified mental 
health professional is required for diagnoses such as Major Depressive Disorder.  
The BDI-II has strong psychometric properties.  Coefficient alpha for the BDI-II was .92 
for 500 outpatients and .93 for 120 college students (Beck et al., 1996).  Test-retest reliability 
was assessed in a sample of 26 outpatients between first and second therapy sessions one week 
apart.  The test-retest correlation coefficient was .93.  Convergent and discriminant validity for 
the BDI-II has also been assessed.  Convergent validity is shown in a positive correlation (r = 
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.37, p < .001) between the BDI-II and the Scale for Suicide Ideation (SSI; Beck, Kovacs, & 
Weissman, 1979) and between the BDI-II and the Beck Hopelessness Scale (BHS; Beck & Steer, 
1988; r = .68).  Both of these measures were shown to positively correlate with depression 
(Beck, Epstein, Brown, & Steer, 1988; Beck & Steer, 1988).  In comparison to the Hamilton 
Rating Scale for Depression (HRSD) and the Hamilton Rating Scale for Anxiety (HRSA), the 
BDI correlates more highly with the HRSD (r = .71) than the HRSA (r = .47; Hamilton, 1959; 
Riskind, Beck, Brown, & Steer, 1987).  Together, these findings support the reliability and 
validity of the BDI-II.  Cronbach’s alpha coefficient was used to assess internal consistency.  In 
the current study, Cronbach alpha coefficients were: (a) .87 at Intake, (b) .86 at Pre-Treatment, 
and (c) .84 at Post-Treatment.  
To be included in this study participants needed BDI-II scores less than 19.  If they 
scored 19 or higher, their file was reviewed by Dr. Bradshaw to decide whether results of the full 
battery of assessments showed them to be good candidates for the study.   
Dissociative Experiences Scale (DES).  This measure was used to assesses dissociative 
experiences of respondents by instructing them to rate percentages of time (0%-100%) they 
experienced various dissociative symptoms, on visual analogue scales (cross hatches on lines; 
Appendix G; Carlson & Putman, 1993, 2015).  All item percentages are added together and 
divided by the number of items (28).  Although there are no clear diagnostic cut-offs, scores 
between 19.2 and 30 may be associated with borderline personality disorder, acute PTSD, or 
severe anxiety disorders.  Scores greater than 36 suggest some form of Dissociative Disorder, 
and scores greater than 48 warrant further testing for Dissociative Identity Disorder (DID).  
Actual levels of dissociation can be much higher than indicated by the results of this assessment, 
because some respondents lack self-awareness regarding their own dissociation.  Cronbach’s 
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alpha coefficient was used to assess internal consistency in the current study, and the coefficient 
was .82. 
To be included in this study, participants needed DES scores less than 30.  If they scored 
30 or higher, their file was reviewed by Dr. Bradshaw to decide whether results of the full 
battery of measures showed them to be good candidates for the study.  See Appendix G for item 
content and layout for this instrument. 
Personal Report of Confidence as a Speaker (PRCS).  To be included in this study, 
participants had to score higher than 15 on this measure.  A cut-off of 16 was chosen because 
this was the point used for determining the clinical sample reported by Paul (1966) during 
development of a shortened form of this instrument, although other researchers have used 
different cut-off scores (Gatchel, Hatch, Maynard, Turns, & Taunton-Blackwood, 1979; Jones, 
Philips, & Rieger, 1995).  The original PRCS consisted of 104 items (Gilkinson, 1942) but was 
shortened by Paul (1966) due to difficulty using the instrument for screening.  The shortened 
PRCS consists of 30 questions related to feelings of confidence as a speaker during respondent’s 
most recent public speaking experiences.  Items are answered true or false (Appendix H).  
Higher scores indicate greater severity of PSA.   
Paul (1966) had two normative groups: (a) a clinical sample, and (b) a non-clinical 
sample.  The clinical sample had 98 subjects, and resulted in a mean score of 20.6 with a 
standard deviation of 3.31.  The mean and standard deviation for the non-clinical sample (n = 
523) were 11.6 and 5.9, respectively.  Philips, Jones, Rieger, and Snell (1997) conducted a study 
to develop norms for the PRCS with 1109 college students.  They considered: (a) age, (b) gender 
(697 women, 412 men), (c) race (752 Caucasians, 316 African Americans, and 41 other races), 
and (c) academic grades, in the evaluation of the PRCS scores. They found no main or 
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interaction effects for age, gender, or race.  The mean score was 14.24 and the standard deviation 
was 7.76.  These findings suggest that age, race, and gender do not significantly affect levels of 
public speaking anxiety using the PRCS. 
Daly (1978) found high internal consistency (Cronbach’s alpha = .91) and positive 
correlations between the PRCS and other speech and social anxiety measures (r = .52 to .97).  
From a behavioural perspective, Tarico, van Velzen, and Altmaier (1986) found that poor speech 
performance was associated with higher scores on the PRCS.  Cronbach’s alpha coefficient was 
used to assess internal consistency in the current study, and the coefficients were: (a) .81 at 
Intake, (b) .81 at Pre-Treatment, and (c) .92 at Post-Treatment. 
Dependent Variable Measures 
 In this section, measures used to assess dependent variables are described (some of which 
were described in the previous section).  Assessment types used in this study included: (a) self-
report measures, (b) psychophysiological assessments, and (c) behavioural analyses.   
The rationale for using all three types of evaluation (self-report, psychophysiological, and 
behavioural) arises from research findings suggesting that subjective accounts of emotional 
experiences alone are not as reliable, complete, or accurate as multimodal assessments which 
include physiological measures (Orr & Roth, 2000).  Davidson (1998), in agreement with Orr 
and Roth (2000), went on to say that it is crucially important that both subjective and objective 
measures be included in future studies, to build stronger evidence for assessment validity.  Lang 
(1988) listed three main ways to measure emotional experiences: (a) overt reactions, (b) self-
report, and (c) physiological changes.  Since many symptoms of public speaking anxiety are 
associated with physiological arousal such as sweating, shaking, or dizziness (Calamaras et al., 
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2014), it seemed logical to include physiological measures.  In light of the research findings and 
arguments mentioned, all three types of assessment were included in this study. 
Self-report.  Three self-report measures were used to asses both broad and narrow 
spectrum symptoms.  Broad versus narrow categorization is decided based on how closely the 
given symptoms are clustered to the core presenting issue (performance-specific SAD).  Broad 
spectrum symptoms assessed were general Anxiety and Depression.  The narrow spectrum 
symptom was confidence as a speaker.  These assessments are described in the following 
sections.  
Personal Report of Confidence as a Speaker.  The assessment used to monitor self- 
reported levels of speaker confidence was the Personal Report of Confidence as a Speaker (Paul, 
1966).  This was the same assessment used during the intake process, and described under Intake 
Assessments, above (view instrument in Appendix H).   
Beck Depression Inventory II (BDI-II).  The assessment used to monitor self-reported 
levels of depressive symptoms was the Beck Depression Inventory II (Beck, Steer, & Brown, 
1996).  This was the same assessment used during the intake process, and described under Intake 
Assessments, above.  
Beck Anxiety Inventory (BAI).  As mentioned, this measure was used to monitor anxiety 
in participants at each assessment time to determine whether outside treatment was warranted 
due to severity of symptoms.  The BAI consists of 21 items describing symptoms of anxiety 
(Beck & Steer, 1993).  These symptoms are rated on 4-point scales from 0 to 3, as follows: (a) 0 
= “not at all,” (b) 1 = “mildly; it did not bother me much,” (c) 2 = “moderately; it was very 
unpleasant, but I could stand it,” (d) 3 = “severely; I could barely stand it”.  Symptoms listed are 
“Numbness and tingling,” “Wobbliness in legs,” “Feeling hot,” “Unable to relax,” “Dizzy or 
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lightheaded,” “Fear of the worst happening,” “Heart pounding or racing,” “Terrified,” 
“Unsteady,” Feelings of choking,” “Nervous,” “Hands trembling,” “Fear of losing control,” 
“Shaky,” “Difficulty breathing,” “Scared,” “Fear of dying,” “Indigestion or discomfort in 
abdomen,” “Face flush,” “Faint,” and “Sweating (not because of heat).”  
This self-administered test takes 10 minutes to complete.  Total score ratings are: (a) 0-7 
= minimal anxiety, (b) 8-15 = mild anxiety, (c) 16-25 = moderate anxiety, or (d) 26-63 = severe 
anxiety.  Reliability of the BAI has been examined in several studies.  Beck et al. (1988) found 
high internal consistency with a Cronbach alpha coefficient of .92.  Fydrich et al. (1990) found 
an even higher alpha coefficient of .94 for internal consistency reliability.  Test-retest reliability 
was assessed with a subsample of 83 outpatients (Beck et al., 1988) tested one week apart, 
resulting in a correlation of .75.   
Several types of validity have been explored for the BAI.  The content of the BAI 
matches the outline for diagnosing patients with anxiety disorders (specifically, panic and 
generalized anxiety disorders).  Much like other anxiety scales (Gotlib & Cane, 1989), the BAI 
has also been found to have moderate correlations with depression scales, such as the Beck 
Depression Inventory (r = .50, p < .001; Fydrich et al., 1990) and the Hamilton Psychiatric 
Rating Scale for Depression - Revised (r = .25, p < .05; Hamilton, 1960).  The BAI is not 
significantly correlated with the Beck Hopelessness Scale (Beck & Steer, 1988) which measures 
negative attitudes regarding the future.  These type of symptoms are more related to depression 
and less with anxiety (Beck, 1967, 1976; Beck & Emery, 1985).  Cronbach’s alpha coefficient 
was used to assess internal consistency and, in the current study, the coefficients were .57 at Pre-
Treatment and .72 at Post-Treatment. 
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Behavioural assessment.  
Timed Behavioural Checklist (TBC).  This measure was used to assess performance 
aspects of PSA.  This checklist was adapted in several ways.  Clevenger and King (1961) 
developed this measure, although the length of the checklist made it difficult to use for clinical 
work (i.e., outside of research studies).  The instrument was shortened by Paul (1966), and 
further amended by Henry (2003).  The initial pool of items for the present study was drawn 
from Henry’s list of 20 behavioural displays of public speaking anxiety, which are assessed in 
30-second intervals over the first two minutes of a speech task.  Two additional symptoms were 
added to the checklist (see items 21 and 22 in Appendix K).  Immediately prior to this study, all 
22 categories were examined using pilot speech samples.  Collection and analysis of pilot data 
was done to: (a) select categories which were a better fit for this application, and (b) identify a 
small number of behavioural observation categories that could be most reliably assessed, to 
clarify and focus the procedure.  These analyses yielded five items with high inter-rater 
reliability and clinical utility.  Items which were retained are 3, 5, 7, 20, and 22.  Criteria that 
were considered when determining item utility were: (a) patterns of inter-rater agreement, (b) 
likelihood of the behaviours being observable in video recordings of speeches, and (c) ease of 
use by observers (raters).  Each rater’s total counts of the five behaviours for all intervals were 
averaged across two raters to achieve a total TBC for each speech task. 
Psychophysiological assessments.  Many symptoms of PSA are associated with 
activation of the limbic system (Calamaras, Anderson, Tannenbaum, & Zimand, 2014), as 
described in polyvagal theory (Porges, 2007).  In this study, limbic system activation was 
assessed via Electrodermal Activity (EDA) measurement.  In the following paragraphs, 
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rationales and procedures for using EDA to measure limbic system activation assessments are 
outlined.   
 Script Driven Symptom Provocation (SDSP).  This assessment procedure is based on 
bioinformational theory, in which it is suggested that the brain stores traumatic memories which, 
in turn, cause psychophysiological responses.  Personal meanings and emotional reactions 
behind traumatic stimuli can be intentionally triggered (Lang, Levin, Miller, & Kozak, 1983; 
Levin, Cook, & Lang, 1982).  Though often applied in laboratory studies of PTSD for veterans 
(Pitman et al., 1987; Pitman, Orr, Forgue, Altman, de Jong, & Herz, 1990) SDSP has been 
applied in studies of anxiety disorders (Levin et al., 1982; Pitman et al., 1990).  More recently, 
SDSP has been applied to study: (a) emotional and cognitive activity associated with PTSD 
before and after OEI Switching (Grace, 2003), (b) psychobiology and psychopharmacology of 
PTSD (van der Kolk, 2001), and (c) positron emission tomography following childhood sexual 
abuse-based PTSD (Shin et al., 1999).  
SDSP was used to ensure consistency in measurement of anxiety over time.  The 
procedure started by having participants summarize their most intense emotional and physical 
reactions associated with PSA using a standardized procedure (van der Kolk, Hopper, & 
Osterman, 2001) and reporting form (Traumatic Scene Form; Hopper & van der Kolk, 2001).  
Next, individualized scripts were created and recorded (50-60 second audio files) for each 
participant.  Finally, these recordings were played for participants during certain EDA 
assessments, to assess the impact of triggering prior to, and following, treatment.  The Traumatic 
Scene form, which participants completed for individualized script creation, can be seen in 
Appendix I.  Participants’ reactions to their scripts were measured via EDA assessments.   
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According to polyvagal theory (Porges, 2007), limbic system structures are activated in 
response to stressful stimuli.  EDA changes as limbic system activity increases during the “fight 
or flight” response (Schwartz & Andrasik, 2003).  A pattern of EDA when recorded scripts were 
played for participants provided information about their reactions to PSA-related traumatic 
events.  EDA has been shown to be a sensitive measurement of sympathetic nervous system 
arousal in response to mental stress, including arousal associated with recollection of upsetting 
events (Neumann & Blanton, 1970).  Galvanic Skin Response (GSR, now known as 
Electrodermal Activity, or EDA) is extremely sensitive to transitory emotions and mental events 
(Schwartz & Andrasik, 2003).  Brown (1974) found EDA to be more responsive to mental events 
than either Electromyography (electrical activity from muscle movement or tension) or 
Thermography (measurement of skin temperature; Neumann & Blanton, 1970).  The protocol for 
EDA assessments can be seen in Appendix J.  
The palm of the hand contains up to 2000 sweat glands in every square centimeter 
(Schwartz & Andrasik, 2003).  When these glands are activated, they can each send micro-
electrical signals along pathways between the deeper, more conductive layers of skin and the 
skin surface.  Skin conductance can be measured by applying two electrodes to the skin to 
monitor sweat gland activity.  When voltage is applied, a circuit is formed and an electric current 
will flow.  Resistance of the skin is dependent on the number of glands that are open.  Such 
resistance will affect the magnitude of the current (according to Ohm’s law).   
Because EDA is associated with arousal, flat or low response patterns are not adaptive for 
humans (Schwartz & Andrasik, 2003).  Persistent minimal arousal, inattentiveness, and flattened 
affect are neither healthy nor adaptive.  There are times when minimal arousal is beneficial, such 
as during relaxation, but there are also times when greater stimulation should occur.  An example 
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of a time when increased arousal is beneficial is when one is confronted with a novel stimulus: 
One needs to be able to recognize and respond to stimuli appropriately.  Once an individual has 
oriented to a stimulus, arousal should return to a baseline level.  People sometimes react to 
stimuli in an overly-sensitive manner (i.e., out of proportion to the threat of the stimulus).  Such 
overreactions require more energy, which results in increased physical tension.  In light of these 
findings, the goal of treatment in this study is to optimize EDA levels in participants, reducing 
over-reactive responses to public speaking. 
Cronbach’s alpha coefficient was used to assess internal consistency.  Calculations were 
run using the 3 EDA baseline activities (see Appendix J).  In the current study, Cronbach’s alpha 
coefficients were .92 at Pre-Treatment and .99 at Post-Treatment. 
Procedure   
Recruitment.  Recruitment was done on a small scale for this initial pilot study through 
several methods, including: (a) word of mouth through representatives of a Department of 
Counselling Psychology and through local Toastmasters leaders, (b) a series of three community 
presentations, and (c) posters throughout the Greater Vancouver and Fraser Valley regions of 
British Columbia.  The poster can be seen in Appendix L.  The most successful form of 
recruitment was word of mouth in the community, followed by the presentations.   
Intake.  The intake process consisted of informed consent and several self-report 
assessments to determine whether respondents fit the criteria described in the Intake Assessment 
portion of this document.  This session began with the informed consent process.  Each 
participant was provided with (a) a document describing the study, and (b) a discussion of both 
the treatments and assessments in the study.  The informed consent document can be seen in 
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Appendix M.  Participants signed the document if they were interested in entering the study.  
After informed consent was complete, intake assessments commenced.  
The order in which the assessments were given was: (a) Personal Report of Confidence as 
a Speaker (Paul, 1966), (b) Severity Measure for Social Anxiety Disorder (Social Phobia) – 
Adult (American Psychiatric Association, 2015b), (c) Severity Measure for Generalized Anxiety 
Disorder – Adult (American Psychiatric Association, 2015a), (d) Severity of Posttraumatic Stress 
Symptoms – Adult (American Psychiatric Association, 2015c), (e) Beck Depression Inventory II 
(BDI-II) (Beck et al., 1996), and (f) Dissociative Experiences Scale (Carlson & Putman, 2015).  
These assessments were used together to determine whether each individual would be a good fit 
for the study.  If participants met criteria for inclusion in the study, they completed the Traumatic 
Scene Form (see Appendix I) which would later be used for Script Driven Symptom Provocation 
assessment.  Those who did not meet the criteria were referred to other community counselling 
services.  
Pre-Treatment and Post-Treatment assessments.  There were two parts to each 
assessment, and both parts were administered at Pre- and Post-Treatment evaluations.  
Part one.   The first part of each evaluation began with self-report instruments, and 
proceeded to baseline EDA assessments.  
Self-report.  Participants were given three self-report instruments to complete. These 
included: (a) BDI-II, (b) BAI, and (c) Severity of Posttraumatic Stress Symptoms – Adult (SPSS-
A) during which participants were asked to consider a socially traumatic (typically, a public 
speaking) situation.  The BAI and BDI were given according to the manualized instructions.  The 
SPSS-A was given according to manualized instructions except that the event listed for the 
traumatic experience did not need to satisfy “Criterion A” for Posttraumatic Stress Disorder 
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according to the Diagnostic and Statistical Manual of Mental Disorders (DSM; American 
Psychiatric Association, 2013).  Instead, a social criterion was used.  Participants were prompted 
to think of socially traumatic events with the following prompt: “Was there a time you felt hurt 
in a group setting in one (or more) of the following ways: (a) Feeling rejected & criticized, (b) 
Feeling humiliated & embarrassed, or (c) Feeling deceived & betrayed?”  After choosing their 
stressful experience participants were asked to write a sentence describing the situation, and to 
indicate the approximate date when the experience occurred.  They then completed the SPSS-A 
according to manualized instructions.  Results of analyses of this assessment are not reported in 
the present report.  After these self-report measures were completed, participants were escorted 
to the psychophysiological laboratory where the next phase of the assessment would occur.  
Baseline psychophysiological assessment.  The next phase of the assessment involved a 
baseline EDA assessment at locations E1 and E2 (see Appendix N; Scheirer, Picard, Tilbury, & 
Farringdon, 2002).  It should be noted that EEG data were collected at the same time, but were 
not included in this thesis.  The protocol for the baseline EDA assessment can be found in 
Appendix J.    
Part two.  The second part of each evaluation consisted of three components.  The first 
involved Script Driven Symptom Provocation (SDSP) with EDA measurements, followed by 
behavioural assessment during a speech task, and finally, a brief self-report (PRCS).  
Script driven symptom provocation with psychophysiological assessment.  This 
psychophysiological measurement involved assessment at the same two EDA locations as the 
baseline.  After a brief (1 minute) baseline, the audio recording of the individualized trauma 
script played for the participant and their EDA reactions were recorded.  This 1-minute trauma 
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script time was followed by a final minute of assessment time with no further trauma stimuli.  
The protocol for this assessment can be seen in Appendix J.   
Behavioural assessment.  The Timed Behavioural Checklist (TBC) was used to assess 
behavioural aspects of public speaking anxiety.  The assessment consisted of video-recording 
five consecutive 30-second periods (during a 3-minute speech task) for later analysis of 
behavioural measures of public speaking anxiety.  These behaviors were coded from video 
recordings by two trained observers (trained and assessed together to maximize consistency of 
measurement).  Total TBC scores incorporated reports averaged across observers, resulting in 
more objective measurements of PSA.  
Participants were asked to stand at the front of a classroom and present 3-minute 
speeches on alphabetical topics provided to the two observers.  The topic for the Pre-Treatment 
assessment had to start with the letter “P”.  The topic for the Post-Treatment assessment had to 
start with the letter “C”.  The full TBC can be found in Appendix K.   
Self-report.  The final phase of the assessment was to complete the PCRS.  This 
assessment was administered immediately after the speech task, so that participants would be 
rating their levels of confidence during a very recent speech.  
Treatment.  There were two treatments used in the study.  The first treatment was 
Observed and Experiential Integration (OEI; a trauma-root-focused treatment) and the alternative 
treatment was Breathing, Relaxation, Autogenics, Imagery, and grounding (BRAIN; a trauma-
symptom-focused treatment).  OEI will be described first.  Finally, results of the Credibility of 
Treatment Questionnaire will be reported, which was used to determine whether participants’ 
expectations, or perceptions, of effectiveness for each treatment likely affected their treatment 
outcomes.   
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Observed and Experiential Integration (OEI)  
Information session.  The information session for OEI involved a PowerPoint 
presentation and a video demonstration of Dr. Bradshaw using OEI to treat public speaking 
anxiety.  Information presented in the PowerPoint presentation can be seen in Appendix O.  A 
homework sheet for OEI was also provided, to help participants remember techniques they could 
use at home between sessions.  This handout can be seen in Appendix P.   
Treatment.  Those in the OEI Group received seven 1-hour session of OEI treatment (at 
the times outlined in the design, presented in Figure 1).  Treatments were conducted by Level II 
certified OEI clinicians.  There were two female Masters-level counselors and one male 
Doctoral-level psychologist.  The psychologist had over 35 years of clinical experience and co-
developed OEI.  The psychologist led the OEI psychoeducational sessions for all participants. 
One of the Masters-level clinicians had over 12 years of experience.  The other Masters-level 
clinician had over three years of experience.  Treatment included all five OEI treatment 
techniques: Switching, Sweeping, Glitch Massaging, Release Points, and Glitch Holding with 
Bilateral Stimulation (Bradshaw et al., 2011).  Each session started with discussion of elements 
of public speaking that provoked the most negative intensity (subjective anxiety) in each 
participant.  Such intensity could include: anger, fear, shame, sadness, and/or somatic 
experiences.  Multisensory expansion with imagery was used to help participants identify, and 
connect with, their anxiety.  Once each participant had a target (or event) clearly in his/her mind 
associated with somatoemotional intensity, the therapist would begin applying the OEI 
Switching technique.  The therapist then tracked through the participant’s visual field(s) using 
either (a) typical Glitch Tracking (based on therapist observation) or “Track-to-Target” (based on 
participant’s subjective report of affect or sensation).  As described in Bradshaw et al. (2011), 
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these “glitches” in eye movement (blinking, squinting, halting, or skipping of eye movement) are 
often connected with distinct emotional or physical experiences.  The Sweep technique was used 
when necessary to dissipate dissociative artefacts (headaches, drowsiness, etc.) if they arose and 
did not dissipate sufficiently with OEI Switching.   
Helpful Aspects of Therapy questionnaire.  Immediately after each treatment session, 
participants completed the Helpful Aspects of Therapy (HAT) questionnaire to assess what they 
found to be most helpful or hindering during the treatment session on that day.  The HAT 
consists of seven questions: (a) four short-answer questions, (b) two multiple-choice questions, 
and (c) an option to briefly describe any outstanding treatment events.  A copy of this form can 
be found in Appendix Q.  Results of this inventory are not included in this thesis report.  
Breathing, Relaxation, Autogenics, Imagery, and grouNding    
Information session.  The information session for BRAIN involved a PowerPoint 
presentation and a video demonstration of Dr. Bradshaw using BRAIN techniques with a client 
to reduce public speaking anxiety.  The PowerPoint presentation can be seen in Appendix R.  
Treatment.  The content of BRAIN sessions included tools and techniques that 
participants could use both at home, and before public speaking tasks, to reduce their stress and 
promote relaxation.  The main techniques included in this collection of techniques are: (a) 
diaphragmatic breathing, (b) progressive muscular relaxation, (c) autogenics, (d) imagery, and 
(e) grounding techniques.  Readers will find an overview of BRAIN techniques in Appendix S.  
These treatments were conducted by the same clinicians who administered the OEI treatment.  
The Psychologist co-developed the BRAIN protocol.  The Psychologist led the BRAIN 
psychoeducational sessions for all participants.  Both Masters-level clinicians were trained by the 
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Psychologist.  Consultations occurred to address treatment fidelity for this clinical team 
throughout the study (initially every two days and later on a weekly basis).  
Helpful Aspects of Therapy questionnaire.  Immediately after treatment, participants 
completed the HAT questionnaire to assess what they found to be most helpful or hindering 
during the treatment session for the day.  As mentioned above, this form consists of seven 
questions: (a) four short-answer, (b) two multiple-choice, and (c) one open-ended, to briefly 
describe any outstanding treatment-related events (see Appendix Q).  Results of this inventory 
are not included in this thesis report. 
Credibility of Treatment Questionnaire (CoTQ).  This measure consists of 6 items, on 
which participants provided ratings of each of the two therapies in the study on 10-point scales, 
immediately following their 2-hour information and demonstration sessions.  These questions 
assess credibility and expectancy for improvement (Borkovec & Nau, 1972).  It should be noted 
that in the larger study from which this thesis emerges, all participants received both therapies 
(including information sessions and CoTQs).  In this way, comparisons in perceptions of the two 
therapies were possible to determine for this thesis.  The purpose of the questionnaire in this 
study was to determine whether differential expectancies of success likely impacted treatment 
outcomes.  The CoTQ can be seen in Appendix T.  Results of the CoTQ suggest that there were 
no differences in how participants saw the two therapies (in terms of credibility or expectancy of 
success).   
A paired-samples t-test was used to assess differences in how credible participants saw 
the two treatments.  There was no significant difference between the therapies: OEI (M = 43.89, 
SD = 4.70) and BRAIN (M = 44.33, SD = 4.56), t(8) = -.36, p = .73 (two-tailed).  The difference 
between means was .44 with a 95% confidence interval from -3.32 to 2.43.  The eta squared 
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statistic (.02) indicates there is a small effect size.  This clearly suggests that different 
expectations for the success of the treatments did not play significant roles in treatment outcome.  
Interview.  After the Post-Treatment assessment, participants were interviewed by Dr. 
Marvin MacDonald.  The purpose of this interview was to add depth and understanding 
regarding the subjective experiences of participants, with hopes of understanding how the 
treatments impacted them.  Questions used in this interview can be seen in Appendix U.  Results 
of these interviews are beyond the scope of this thesis project but will be reported in future 
publications.  
Analysis 
A pilot study design with a small sample size allows for descriptive examination for 
selection of measures for future research.  In this study, parametric analysis was chosen to 
describe the relationships among interval-level variables.  The interval-level variables used were: 
(a) established self-report measures (PRCS, BAI, and BDI-II), (b) frequency of behaviour in the 
performance tasks (TBC), and (c) a physiological component of anxiety (EDA).  Because the 
low power prevented inferential analysis, effect size descriptions were used to guide evaluation 
of protocol performance in this pilot study.  
Measures were evaluated for utility based on the principals of sensitivity and specificity 
(Sox, 1986).  For the purposes of the present study, the definition of sensitivity is the proportion 
of accurate positive indicators of an index state (high anxiety).  Specificity is defined as the 
proportion of accurate negative indicators of an index state (low anxiety).  The results of 
parametric analysis to descriptively evaluate sensitivity and specificity will help develop stronger 
protocols for future studies.  
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CHAPTER 4: RESULTS 
Preliminary Analysis   
This pilot study was designed with a small sample size to allow for descriptive 
examination for selection of measures for future research.  Parametric analysis was chosen to 
describe the relationships among interval-level variables.  Assumptions of normality, 
homoscedasticity (homogeneity of variance), and reliability underlie inferential and descriptive 
parametric analyses.  
Reliability (internal consistency) was assessed using Cronbach’s Alpha for psychometric 
instruments used in this study (PRCS, SMSAD-A, SMGAD-A, SPSS-A, DES, BDI-II, EDA, 
BAI) and psychophysiological assessments.  These coefficients can be seen in Table 1.   
Normality for each instrument (at each administration) was assessed using the 
Kolmogorov-Smirnov test of normality.  Normality was assessed for each 1-minute activity 
during EDA assessments.  All assessments satisfied the assumption of normality except: (a) Pre-
Treatment script-driven EDA; (b) Post-Treatment BDI; and (c) Post-Treatment baseline EDA.  
Logarithm or Square Root transformations were applied to these variables, resulting in 
satisfaction of the normality assumption in each case.  Since the assumption of normality was not 
met for the BDI-II at Post-Treatment, a Square Root transformation was applied to both Pre-
Treatment and Post-Treatment scores.  After transformation the Post-Treatment distribution of 
BDI-II scores met the assumption of normality according to the Kolmogorov-Smirnov test. 
To check the equality of error variance (homoscedasticity), Levene’s Test was used.  
Every administration of each instrument satisfied the assumption of homoscedasticity (p > .05).  
Box’s Test for equality of covariance matrices was also used, and it was apparent that no data 
violated this assumption.  
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Table 1  
Measurement Reliability 
 Intake Pre-treatment Post-treatment 
PRCS 0.81 0.81 0.92 
SMSAD-A 0.9 - - 
SMGAD-A 0.73 - - 
SPSS-A 0.79 - - 
DES 0.82 - - 
BDI-II 0.87 0.86 0.84 
EDA - 0.92 0.99 
BAI - 0.57 0.72 
Note:  The full titles for each measurement are as follows, the: (a) PRCS is Personal Report of Confidence as a 
Speaker, (b) SMSAD-A is Severity Measure for Social Anxiety Disorder (Social Phobia) – Adult, (c) SMSAD-A is 
Severity Measure for Generalized Anxiety Disorder – Adult, (d) SPSS-A is Severity of Posttraumatic Stress 
Symptoms – Adult, (e) DES is Dissociative Experiences Scale, (f) BDI-II is Beck Depression Inventory II, and (g) 
BAI is Beck Anxiety Inventory.  The (a) EDA and BAI were not administered during the Intake process and (b) the 
SMSAD-A, SMGAD-A, SPSS-A, and DES were not administered during Pre-Treatment or Post-Treatment 
assessments.   
 
 Many of the assumption checks are tied to the practice of inferential statistics.  
Descriptive analyses will rely on conventional uses of effect size descriptions: (a) .14 and greater 
are large effects, (b) .06 to .13 are medium effect, and (c) .05 and lower are small effects (Cohen, 
1988).   
Research Questions 1-3 
The research questions address (a) treatment effects, (b) time effects, and (c) specificity 
effects. These effects are explored for all the measures in the treatment protocol.  Each category 
of measures is presented below in the sequence of: (a) self-report, (b) behavioural, and (c) 
psychophysiological.  Descriptive statistics for each measure are presented in Appendix V.  After 
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the overall ANOVA results are presented for each measure, implications for research questions 1 
to 3 are summarized.   
Self report measures.  The self report measures examined in this study were: (a) 
Personal Report of Confidence as a Speaker (PRCS), (b) Beck Anxiety Inventory (BAI), and (c) 
Beck Depression Inventory II (BDI-II).  
In addition to the narrow spectrum assessments (those closely associated with 
performance-specific Social Anxiety Disorder [SAD]) used in this study, two broad spectrum 
symptom patterns were assessed: Depression and Anxiety were assessed using the Beck 
Depression Inventory II and the Beck Anxiety Inventory, respectively.  Anxiety and depression 
are very common in mental health and clinical work settings in general.  Both are also evident in 
research findings that show high prevalence rates and considerable comorbidity with specific 
phobias like performance-specific SAD (American Psychiatric Association, 2013).  In light of 
such comorbidity, the BDI-II and BAI were included in this study.  Of greatest interest was the 
impact of OEI on broad spectrum symptoms.  
Personal Report of Confidence as a Speaker (PRCS).  Mixed between-within subjects 
ANOVA (2 X 2) was conducted.  The interaction effect between time and group was small and 
nonsignificant, Wilk’s Λ = .97, F (1, 7) = .25, p = .633, η2 = 0.034.  There was a large main 
effect for time, Wilk’s Λ = 0.39, F (1, 7) = 10.78, p = .013, η2 = .606, and it was so large that is 
also happened to be statistically significant even in the small sample.  Participants in both groups 
showed reductions in self-reported PSA from Pre- to Post-Treatment (approximately 5 points for 
OEI and 6 points for BRAIN).  There was a negligible group main effect, F (1, 7) = .13, p = 
.731, η2 = .018.  There was a large effect size for the within subjects main effect but effect sizes 
for between subjects and interaction effects were very small.  Both treatments have the same 
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impact on the confidence as a speaker of the participants.  These scores show increasing 
confidence for all participants.  
Beck Depression Inventory II (BDI-II).  Results for both non-transformed and 
transformed scores are provided to show the robustness of results despite the presence of 
skewness and/or kurtosis.  Similar results were obtained for both versions of the analysis. 
Untransformed scores analysis.  A mixed between-within subjects ANOVA (2 X 2) was 
conducted using untransformed BDI-II scores.  The interaction effect between time and group 
was large, Wilk’s Λ = .29, F (2, 7) = 17.17, p = .0.004, η2 = .710, and it was so large that it also 
happened to be statistically significant, even in the small sample.  There was a moderate effect 
for time which was non-significant, Wilk’s Λ = 0.87, F (1, 7) = 1.07, p = .335, η2 = .133.  There 
was a large between-subjects effect which was non-significant, F (2, 7) = 2.57, p = .153, η2 = 
.268.  Refer to Figure 1 for a visual plot of these relationships. 
Transformed Scores Analysis.  A mixed between-within subjects ANOVA (2 X 2) was 
conducted using square root transformed variables of both Pre- and Post-Treatment BDI scores.  
There was a large interaction effect between time and group, Wilk’s Λ = .36, F (2, 7) = 12.7, p = 
.0.009, η2 = .644, and it was so large that it also happened to be statistically significant, even in 
the small sample.  There was moderate effect for time which was non-significant, Wilk’s Λ = 
0.87, F (1, 7) = 1.06, p = .338, η2 = .131.  There was a large between-subjects effect which was 
non-significant, F (2, 7) = 1.91, p = .210, η2 = .214.  Figure 1 adequately describes the 
interaction effect for the transformed scores as well.  
 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  68 
 
Figure 1.  Beck Depression Inventory II (BDI-II) ANOVA Plot for changes from Pre-
Treatment to Post-Treatment assessments for the (a) Observed and Experiential Integration 
(OEI) and and (b) Breathing, Relaxation, Autogenics, Imagery, and grouNding (BRAIN). 
 
Beck Anxiety Inventory (BAI).  A mixed between-within subjects ANOVA (2 X 2) was 
conducted.  There was a large interaction effect between time and group which was non-
significant at conventional alpha levels, Λ = .58, F (1, 6) = 4.42, p = .080, η = .424.  If, however, 
we used an alpha level of .1 (suggested by Stevens [1996] for small sample sizes), this effect 
becomes significant.  There was a moderate effect for time which was non-significant, Λ = 0.92, 
F (1, 6) = .56, p = .484, η = .085.  There was a large between-subjects effect which was non-
significant, F (1, 7) = 5.418, p = .059, η = .475.  Between group differences did not mask clinical 
effects in this sample, and this pattern may well hold for future samples. 
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Figure 2.  Beck Anxiety Inventory plot of cell means for changes from Pre-Treatment to 
Post-Treatment assessment times for the (a) Observed and Experiential Integration (OEI) and 
and (b) Breathing, Relaxation, Autogenics, Imagery, and grouNding (BRAIN).  
 
Self report summary.   The research questions refer to: (a) interaction effect, (b) 
sensitivity to change over time, and (c) specificity.  Some self-report measures showed greater 
sensitivity and specificity than others.  As a whole, the self-report measures did show utility in 
understanding the impact of these two treatments for this population.   
The three self-report measures were the: (a) PRCS, (b) BDI-II, and (c) the BAI.  The 
PRCS shows no sensitivity to differential treatment effects.  The PRCS did show that confidence 
reflects sensitivity to change over time.  The PRCS did not, however, show specificity as both 
treatments addressed the confidence based symptoms assessed by this measure.  The BDI-II 
shows strong sensitivity to differential treatment effects.  Time effects for the BDI-II show up for 
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the two treatment groups in different directions.  The BDI-II showed specificity by 
demonstrating a beneficial impact of the trauma-root-focused treatment while the trauma-
symptom-focused treatment actually showed a sensitization effect.  Similarly, the BAI shows 
strong sensitivity to differential treatment effects.  Time effects for the BAI show up for the two 
treatment groups in different directions.  The BAI showed specificity by revealing a beneficial 
impact of the trauma-root-focused treatment while the trauma-symptom-focused treatment 
actually showed a sensitization effect.  The PRCS tends to show similar patterns for the trauma-
root-focused and trauma-symptom-focused treatments.  On the other hand, the BDI-II and the 
BAI tend to show the differential effects of the two types of treatment.  The depression and 
anxiety symptoms show positive responses to the trauma-root-focused treatment while the 
confidence measure shows beneficial results of both the trauma-root-focused treatment and the 
trauma-symptom-focused treatment.  
 Behavioural measures.  The behavioural measure used in this study was the Timed 
Behavioural Checklist (TBC).  
Timed Behavioural Checklist.  A mixed between-within subjects ANOVA (2 X 2) was 
conducted.  There was no interaction effect between time and group, Wilk’s Λ = 1.00, F (2, 7) = 
.00, p = .976, η2 = 0.000.  There was a large effect for time, Wilk’s Λ = 0.33, F (1, 7) = 14.56, p 
= .007, η2 = .675, and it was large enough that it also was statistically significant in the small 
sample.  All participants showed reduced scores on the TBC, indicating lower levels of 
performance-specific SAD behaviours.  There was a moderate between-subjects main effect 
which was non-significant, F (1, 7) = .1.09, p = .332, η2 = .134.   
 In summary, the TBC showed no sensitivity to differential treatment effects.  The TBC 
did show sensitivity to change over time.  As can be seen in the descriptive statistics in Appendix 
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V, there were approximately 14 point drops in mean scores for both the OEI and BRAIN groups 
from Pre- to Post-Treatment.  The TBC showed a lack of substantial specificity, because the 
TBC tended to show similar patterns for the trauma-root-focused and trauma-symptom-focused 
treatment groups.  
 Psychophysiological measure.  The psychophysiological assessment used in this study 
was electro dermal activity (EDA).  Baseline level of EDA was compared to a script driven 
symptom provocation (SDSP) condition level of EDA.  
Electrodermal Activity (EDA).  A mixed between-within subjects ANOVA (2 X 2) was 
conducted.  Baseline data and SDSP data analysis was conducted for each of two time periods 
(Pre-Treatment and Post-Treatment).  Two ANOVA analyses were run on the EDA data: (a) Pre-
Treatment baseline EDA in comparison to Pre-Treatment SDSP EDA, and (b) Post-Treatment 
baseline EDA in comparison to Post-Treatment SDSP EDA.  Results of these two ANOVA 
procedures were descriptively compared.  The OEI group showed less psychophysiological 
increase than did the BRAIN group, from baseline to SDSP at Post-Treatment.  This pattern was 
not present at the pre-treatment assessment time.  
Pre-treatment EDA results.  A Mixed between-within subjects ANOVA (2 X 2) was used 
to evaluate the impact of OEI and BRAIN on EDA levels across two conditions (baseline and 
SDSP).  There was no interaction effect between triggering and group, Wilk’s Λ = .99, F (1, 7) = 
.154, p = .702, η2 = .014.  There was a large effect for triggering, Wilk’s Λ = .70, F (1, 7) = 4.75, 
p = .052, η2 = .302, nearly meeting conventional significance levels.  Both groups showed 
increased EDA activity when the trauma script was played.  There was no between-subjects 
effect, F (1, 7) = .13, p = .725, η2 = .012.  These results suggest that (a) both groups responded to 
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the trigger with increased EDA levels, and (b) the groups did not differ in how they reacted to 
the Pre-Treatment SDSP condition.  
Post-treatment EDA results.  A mixed between-within subjects ANOVA (2 X 2) was 
used to evaluate the impact of OEI and BRAIN on EDA levels across two conditions (baseline 
and SDSP).  There was a large interaction effect between triggering and group which was non-
significant, Wilk’s Λ = .77, F (2, 7) = 2.36, p = .163, η2 = .228 (See Figure 3).  The 23% effect 
size is large, but not statistically significant because of the low power of the test with this small 
sample.  This pattern shows a tendency for the OEI group to increase less (from baseline) in 
response to SDSP than the BRAIN group at Post-Treatment.  There was a large main effect for 
triggering, Wilk’s Λ = .56, F (1, 7) = 6.41, p = .035, η2 = .445, and it was so large, that is also 
happened to be statistically significant, even in the small sample.  Participants showed increased 
EDA levels from baseline when triggered with SDSP.  There was a moderately large between-
subjects effect which was non-significant, F (2, 7) = 2.11, p = .184, η2 = .209.  Descriptively, it is 
helpful to see this pattern displayed in the plot below (Figure 1).  
Psychophysiological measurement summary.  The research questions have been 
presented in a specific order.  (a) Research question one refers to the treatment effect of OEI 
when compared to BRAIN.  This question is answered by the descriptive comparison of the pre-
treatment analysis to the post-treatment analysis.  Since the OEI group showed less sensitivity to 
SDSP at post-treatment but not a pre-treatment assessment, the contrast between these two 
analyses suggest that EDA measures can detect differential treatment effects.  (b) Research 
question two examines sensitivity to change over time of treatment effects.  EDA is a sensitive 
measure to triggering (SDSP) effects for both treatment groups.  (c) Research question three 
exams specificity between the treatment groups.  The pre-treatment EDA analysis does not 
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suggest any specificity between BRAIN and OEI.  This simply shows the groups were similar in 
response to the SDSP condition at pre-treatment assessment.  The post-treatment assessment 
shows specificity between groups since the OEI group displayed reduced reactivity to SDSP.  
Thus the EDA measure seems capable of demonstrating specificity since the lack of specificity at 
pre-treatment contrasted with the specificity evident at post-treatment.  
 
Figure 3.   Plot of cell means for Electrodermal Activity (EDA) changes from Baseline to 
Script Driven Symptom Provocation (SDSP) for two groups at Post-Treatment assessment time: 
(a) Observed and Experiential Integration (OEI) and (b) Breathing, Relaxation, Autogenics, 
Imagery, and grouNding (BRAIN).   
 
Results Summary   
The self-report, behavioural, and psychophysiological measures showed utility in 
understanding how both the trauma-root-focused and the trauma-symptom-focused treatment 
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groups shaped the symptoms of performance-specific Social Anxiety Disorder.  Different 
measures focused on different processes addressed in treatment and thus displayed different 
patterns of sensitivity and specificity.  The various processes measured with these assessments 
are: (a) confidence, (b) depression, (c) general anxiety, (d) speaking behaviour, and (e) 
psychophysiological arousal.  These can be separated into three categories of processes: (a) 
narrow spectrum symptoms, (b) broad spectrum symptoms, and (c) psychophysiological 
symptoms.  Narrow spectrum symptoms are: (a) speaking confidence, and (b) speaking 
behaviour.  Broad spectrum symptoms are: (a) depression and (b) anxiety.  The 
psychophysiological symptom was EDA.  The focused of treatment (trauma-root-focused versus 
trauma-symptom focused) impacted which processes were activated for change.  
The self-report measures displayed this differentiation clearly.  The confidence measure, 
PRCS: (a) did not show differential sensitivity to treatment, (b) was sensitive to time, and (c) did 
not show specificity because both treatments affected confidence in the same way.  The BDI-II 
showed: (a) high differential sensitivity to treatment; (b) time sensitivity for the two groups, in 
light of the differential sensitivity in the interaction (research question 1) shown by contrasting 
directions for the two treatment groups; and (c) high specificity because OEI activated a process 
of treatment which impacted depressive symptoms which BRAIN did not activate.  The BAI 
showed: (a) high sensitivity to treatment, (b) differential time sensitivity for the two groups, and 
(c) high specificity because OEI addressed a process of treatment which impacted anxious 
symptoms which BRAIN did not address.  These measures give a great deal of information about 
how self-report assessments show how treatments impact various symptom processes. 
The behavioural measure, TBC, showed: (a) low sensitivity to differential treatment 
effects, (b) high sensitivity for time, and (c) low specificity because both treatments activated 
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behavioural processes.  The moderate between groups effect size (13%) might be worth 
exploring in future research if this strength of relationship is replicated.  
The psychophysiological results, Electrodermal Activity (EDA), were shown through a 
comparison of two analyses: (a) pre-treatment comparison of reactivity for the two treatment 
groups and (b) a post-treatment comparison of reactivity for the two treatment groups.  The 
comparison of the pre-treatment and post-treatment results showed (a) differential treatment 
effects, the pre-treatment analysis showed no differential reactivity between treatment groups but 
the post-treatment groups demonstrated a decrease in reactivity in the OEI group.  The 
comparison of the pre-treatment and post-treatment results showed (b) a strong sensitivity for 
time for both groups.  The comparison of the pre-treatment and post-treatment results showed (c) 
specificity through a shift from a non-specific pattern of triggering at pre-treatment while 
specificity at post-treatment showed through decreased levels of triggering for the OEI group.  
The significance of the results pattern becomes clearer when displayed in Appendix W.  
There appear to be broad spectrum symptoms, narrow spectrum symptoms, and 
psychophysiological symptoms.  The two types of treatment (trauma-symptom-focused versus 
trauma-root-focused) are presented using concentric circles associated with the processes 
activated by the respective treatments.  The trauma-root-focused treatment activates processes 
beyond the scope of the processes activated by the trauma-symptom-focused treatment.  Note 
that self-report instruments fell both within the trauma-root-focused treatment and the trauma-
symptom-focused treatment.  It is important to recognize the value of using multiple types of 
assessment to encompass broad and narrow spectrum symptom change as a result of various 
treatment methods.  
 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  76 
CHAPTER 5: DISCUSSION 
This project constitutes a contribution to previous knowledge in the areas of (a) protocol 
development for clinical research in performance-specific Social Anxiety Disorder (SAD), (b) 
application of trauma theory and treatments used in this study, and (c) added understanding of 
narrow versus broad spectrum symptom change.  Finally, recommendations will be made for 
further protocol development for clinical research on SAD which addresses psychophysiological 
activation.  
Reflections on Innovation in Protocol Design and Theory Application 
Protocol design.  Protocol development is important for emerging directions in clinical 
research, to guide researchers’ choices of treatment models and assessment procedures.  In this 
study, the focus for protocol development for clinical research in performance-specific SAD was 
the interaction between treatment type and symptom processes that were activated.  Examining a 
range of measurement strategies showed how different treatments activated different processes 
for our participants.  The diagram in Appendix W displays the integration of these principles.   
Patterns of results revealed connections between treatment types and which symptom 
processes were activated.  The diagram in Appendix W shows this pattern of interconnections.  
Symptoms can be distinguished as: (a) narrow spectrum symptoms, such as speaker confidence 
and public speaking behaviour (light grey); (b) psychophysiological symptoms, such as 
electrodermal activity (medium grey); and (c) broad spectrum symptoms, such as general anxiety 
and depression (darker grey).  The two treatment types employed in this study are represented in 
the figure by concentric circles, where the trauma-root-focused treatment (solid line) includes 
items within the trauma-symptom-focused circle (dashed line).  As shown in the results and 
displayed in the diagram in Appendix W, the trauma-symptom-focused treatment seemed to 
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activate processes of (a) speaker confidence and (b) speaking behaviour.  These processes were 
also activated by the trauma-root-focused treatment.  In addition to those processes, the trauma-
root-focused treatment activated movement (toward improvement) of the processes of: (a) 
electrodermal activation in response to a trigger, (b) general anxiety, and (c) depression.  In 
response to trauma-root-focused treatment: (a) broad spectrum symptoms improve and (b) 
psychophysiological activation associated with past traumatic social experiences is alleviated.  
Diverse types of measurements, such as self report, behaviour sampling, and 
psychophysiological measures, will be helpful in understanding broad spectrum, narrow 
spectrum, and psychophysiological symptoms.  
Application of trauma theory.  Innovative applications of trauma treatments were 
implemented in this study for reducing anxiety symptoms.  The similarity of trauma and anxiety 
symptoms suggested a traumatic root to performance-specific SAD (Calamaras, Anderson, 
Tannenbaum, & Zimand, 2014; Erwin et al., 2006; Stein, Walker, & Forde, 1996).  This 
relationship was supported by the descriptive analyses in this study.  All participants in the study 
reported memories of socially traumatic events, which left them feeling: (a) rejected and 
criticized, (b) humiliated and embarrassed, and/or (c) deceived and betrayed.  All but one of 
these traumatic experiences related directly to public speaking.  The connection between trauma 
and anxiety suggests the utility of applying trauma theory and treatment for performance-specific 
SAD (Erwin et al., 2006).  
It is worth noting that the different trauma treatments activated different symptoms 
processes.  The assessments in this study showed utility in differentiating between a trauma-root-
focused treatment and a trauma-symptom-focused treatment.  Descriptive analysis of the 
assessments for the trauma-root-focused treatment group showed improved: (a) speaker 
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confidence, (b) public speaking behaviour, (c) EDA reactivity, (d) general anxiety, and (e) 
depression.  The trauma-symptom-focused treatment descriptive analyses results showed 
improved: (a) speaker confidence and (b) public speaking behaviour.  It would appear different 
treatment foci impact which processes are activated for improvement.  The trauma-root-focused 
treatment seemed to impact processes which lay at a deeper level of emotional experience 
(Porges, 2007; van der Kolk, 2001, 2002; Yehuda, 1997, 2002).  The impact of OEI, the trauma-
root-focused treatment, on electrodermal activation indicates the hyperarousal and hyper 
activation responses to triggers are decreased after treatment.  This coincides with the polyvagal 
theory of physiological activation to threat, which appears out of context in traumatized 
individuals.  This treatment may allow clients to live life with less physiological fear and to 
lower their baseline levels of anxiety and trauma.  
 The connection between trauma and anxiety, supported through descriptive analyses of 
this study, contributes to trauma-informed research and clinical practice.  Anxiety can be as 
crippling as trauma, stopping many people from living the lives they desire.  The similarity 
between trauma and anxiety symptoms is important when considering treatment for individuals 
with anxiety.  If this obvious similarity is neglected, clients may not receive the necessary 
treatment.  Anxiety reduction is multifaceted, including physiological, cognitive, behavioural, 
and emotional changes.  Therapists will miss a large aspect of anxiety if treatment neglects the 
physiological impact of socially traumatic events (Porges, 2007; van der Kolk, 2001, 2002; 
Yehuda, 1997, 2002).  In addition to other mechanisms of change, OEI addresses 
neurobiological (sympathetic and parasympathetic nervous system) arousal, including emotional 
and psychophysiological sequelae of socially traumatic memories (see Appendix E for a more 
thorough presentation of how OEI incorporates other theoretical mechanisms of change).  This 
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frees clients, so they can better access and use their higher-order thinking capacities during 
public speaking and other performance tasks.  It is hypothesized that this integration of limbic 
and cortical functioning could empower clients to heal in more comprehensive ways.   
Broad and narrow spectrum symptoms.  Reduction in depression (BDI-II scores) for 
the OEI group was interesting, considering that reductions in BDI-II scores were not found in a 
previous OEI study (Williams, Bradshaw, McDonald, & Blake, 2006).  Two differences in OEI 
treatment protocols may explain this disparity in findings: First, only three hours of OEI 
treatment were administered in the Williams et al. study whereas seven hours of OEI were 
provided in the current study.  Depression may be a peripheral symptom which does not change 
until (a) longer treatment has occurred, or (b) the central symptoms have been addressed. 
Secondly, in the Williams et al. study, a highly manualized version of OEI treatment was used, 
targeting treatment of each participant’s specific sexual assault traumas.  In the current study, 
OEI treatment was targeted on a broader range of experiences identified by participants.  Rather 
than keeping treatment exclusively focused on public speaking targets, therapists were instructed 
to let participants guide their sessions, with targets that spontaneously emerged from focusing on 
their negative emotions and intense physiological experiences associated with performance-
specific SAD.  Treatment with a highly manualized form of OEI to address narrow spectrum 
symptoms (sexual assault traumas, in the Williams et al. study) would be expected to show 
improvement in targeted narrow spectrum symptoms (as was the finding in the Williams et al. 
study).  Less tightly targeted OEI treatment in the current study resulted in reductions of both 
narrow spectrum (behaviour and self-reported confidence) and broad spectrum (depression and 
anxiety) symptoms.   
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Recommendations for Additional Protocol Development and Research 
This portion of the discussion is provided to delineate parameters of the study and to 
make suggestions for future research on performance-specific SAD.  The elements addressed 
are: (a) sampling methods, (b) psychophysiological assessments, (c) broad spectrum symptom 
patterns, and (d) treatment targets.  Following these, will be suggestions regarding how these 
elements can be used together to inform future research design.  
The sample size was intentionally small to permit pilot testing of the complex design and 
assessment processes implemented in this project.  The purpose of the small size was to 
determine what adjustments would be necessary in both assessment and treatment protocols for 
future studies.  No attempt was made to collect a sample from a large geographical catchment 
area, thereby limiting the generalizability of results to a larger population.  Participant samples in 
future research studies should be large enough to support statistical inference with adequate 
power, and selected from wide geographical regions.  Broadening the recruitment area and 
increasing sample size will improve the generalizability of findings.  The decisions on sample 
size for this study allowed for descriptive analysis of the data to provide information for protocol 
design in future research.  
Exploration of EDA assessment revealed rewarding applications for future research 
involving psychophysiological correlates of anxiety.  This strategy could be an innovative way to 
gain more comprehensive understanding of symptom patterns in future research.  
Psychophysiological assessment also permitted documentation of reductions in triggered 
emotional reactions (reactivity), which would not have been possible with self-report or 
behavioural observations (at least not at the same level of measurement sensitivity).  
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The BDI-II and BAI should clearly be used at intake, and in all subsequent assessments, 
along with measurements of narrow spectrum symptoms.  These instruments showed promise for 
detecting group differences in broad spectrum symptom patterns.  It will be valuable for future 
clinical practice and research to assess how, and why, OEI impacts broad spectrum symptoms 
like depression and anxiety.  
In this study, OEI treatment was not tightly targeted at Public Speaking Anxiety stories.  
This could be seen as a limitation, if researchers were only considering narrow spectrum (PSA) 
symptoms.  Results of this study, however, support continued therapist flexibility to deliver 
client-centered OEI treatment: Such treatment resulted in improvements for both narrow 
spectrum (behaviour and self-reported confidence) and broad spectrum (depression and anxiety) 
symptoms.    
Future OEI treatment in research studies should be administered (a) in a variety of 
contexts, (b) at different levels of target specificity, and (c) with variations in treatment dosage 
and scheduling.  In some future OEI studies, sessions could be more tightly focused on 
performance-specific SAD targets to more intensively treat narrow spectrum symptoms.  This 
could involve: (a) target redirection by therapists, (b) script-driven symptom provocation in 
sessions, and/or (c) virtual reality exposure.  In other future studies, OEI target specification 
should permit participant-directed target selection allowing treatment to reduce broad spectrum 
symptoms along with the narrow spectrum symptom change.  When applying less stringent 
target selection, therapy duration may need to be increased to permit clients to work through 
more trauma-root-based experiences.  More general treatment which begins with the “person-as-
a-whole” will likely facilitate processing of core early traumas.  After those core traumas have 
been addressed, participants may naturally return to narrow spectrum symptom targets, or 
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reduction in narrow spectrum symptoms may occur alongside the trauma processing, as was the 
case in this study.  Variations in targeting and duration of OEI treatment will reveal more 
precisely how OEI affects symptoms.  
These suggestions for future research will improve: (a) generalizability of findings; (b) 
potency of treatment; and (c) assessment of the effects of OEI on broad spectrum, narrow 
spectrum, and psychophysiological symptoms.  Continued research on OEI will provide greater 
insight regarding how this treatment can best be used to help clients in therapy. 
Conclusion  
 The findings of this study will be useful for establishing key parameters for development 
of clinical research for social anxiety.  These innovative approaches to clinical research on social 
anxiety address psychophysiological activation.  There is clear support for application of trauma 
treatment to treatment of performance-specific SAD.  If these patterns continue to be supported 
by additional research this will help: (a) those with performance-specific SAD, (b) clinicians, 
and (c) future researchers.  Both OEI and BRAIN were effective in improving the performance-
specific SAD symptoms of speaker confidence and speaking behaviour.  After treatment, 
psychophysiological (EDA) assessments revealed that the OEI group was less reactive to 
triggered reminders of social traumas than the BRAIN group.  More stringent therapeutic focus 
on performance-specific SAD targets during OEI treatment may lead to superior outcomes in 
terms of narrow spectrum symptoms while less tightly targeted treatment may allow for greater 
reductions in broad spectrum symptoms like depression and general anxiety alongside narrow 
spectrum symptom improvement.  The findings of this study will be beneficial for enhancing 
assessment and treatment protocols in future clinical research for performance-specific SAD.   
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Based on community survey results, there is potential to help the one-third of the 
individuals in the general population who experience performance-specific SAD (Kessler, Stein, 
& Berglund, 1998; Stein, Walker, & Forde, 1996).  Research indicates that those with 
performance-specific SAD have higher unemployment rates, lower incomes, and lower 
education levels than those who do not (Calamaras, Anderson, Tannenbaum, & Zimand, 2014).  
These findings suggest that treatment for performance-specific Social Anxiety Disorder will help 
people to reach their vocational, financial, and educational goals and, in turn, make contributions 
to society.   
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APPENDIX A: Research Design Diagram 
Please note that this diagram includes research design aspects which are beyond the scope of this 
thesis document but which will be included in future reports on this data.  
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APPENDIX B: Polyvagal Theory Diagram 
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APPENDIX C: Polyvagal Theory Applied to OEI Treatment Diagram 
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APPENDIX D: Polyvagal Theory Applied to BRAIN Treatment Diagram 
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Appendix E: A Conceptual/Theoretical Summary of OEI 
 
Prepared by 
Dr. Rick Bradshaw 
(February 2017) 
______________________________________________________________________________ 
Observed and Experiential Integration (OEI) can be considered from a number of 
theoretical perspectives (Bradshaw, Cook, & McDonald, 2011).  In this brief review, the major 
theoretical lenses through which OEI can be understood are presented, starting with a 
Behavioural/ Neurobiological lens, because it is so foundational to understanding how and why 
OEI “works”. 
Behavioural/Neurobiological 
It is believed that interoceptive states associated with amygdaloid arousal become 
classically conditioned with relative states of tension in the extraocular and intraocular muscles 
of trauma survivors (including the left and right levator palpebrae superioris muscles which raise 
and lower the eyelids).  This is achieved through the mechanism of ocular proprioception.  
Proprioceptive neurons, which exist in large numbers and high densities in the muscles of the 
eyes and the neck, send messages back to the brain indicating the relative positions and 
movements of the eyes.  Intraocular muscles that constrict and dilate the pupil, and adjust tension 
in the lenses of the eyes, send messages that indicate whether people or objects were approaching 
or moving away (and the distances from the eyes of those people and objects) at the times trauma 
survivors were most overwhelmed (i.e., in states of amygdaloid arousal). 
When trauma survivors revisit the times in their lives when they were most overwhelmed 
(i.e., when their bodies were adrenalized) by thinking about the faces of people, scenes or places, 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  105 
and even somato-affective states, their eyes typically respond by blinking, halting, or skipping in 
response to movement sequences guided by therapists.  In this way, clients and their therapists 
can identify movement patterns, locations in the visual fields, and distances from the eyes, that 
are now (and were then, during traumas) associated with physical and emotional intensity.  By 
guiding the eyes in directions opposite to those associated with the original traumas, typically the 
intensity that patients experience diminishes in a matter of minutes or hours (depending on how 
early and how intense these experiences were). 
In the 68-page foundational article on OEI (Bradshaw, Cook, & McDonald, 2011), other 
neurobiological mechanisms are suggested for the remaining four sets of OEI techniques. 
Psychoanalytic/Psychodynamic 
The neurobiological/behavioural foundation of OEI theory is supplemented by 
assimilation of a number of psychoanalytic/psychodynamic concepts.  Recently, there have been 
entire psychotherapies based on exploration and resolution of transference reactions.  One 
evidence-based therapy for treatment of patients with personality disorders is known as 
“Transference-Focused Psychotherapy” (Yeomans, Clarkin, & Kernberg, 2002).  It is based on 
years of theoretical work by object relations therapist Otto Kernberg (Clarkin, Yeomans, & 
Kernberg, 1999; Kernberg, Selzer, Koenigsberg, Carr, & Appelbaum, 1989; Koenigsberg, 
Kernberg, Stone, Appelbaum, Yeomans, & Diamond, 2000).   
During early applications of OEI, it was discovered that many patients with early and 
severe abuse and neglect manifested negative transference reactions toward their therapists.  
These can be detected by having patients simply cover one of their eyes and look at the therapist, 
and then switch to cover the other eye and compare their perceptions of the therapist.  It is not 
unusual, particularly in patients with personality disorders, to see major differences in the visual 
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perceptions that clients have of their therapists, depending on which I is covered.  Typically, this 
manifests as differences in perceived physical distance from the therapist, and/or differences in 
appearance of the therapist (e.g., critical and angry with one eye open, but accepting and warm 
with the other eye open).  In extreme cases, the therapist may appear to have no face with one 
eye open, or to appear as if she or he is a past abuser). 
Therapeutically, the great benefit of OEI is that these negative transference reactions can 
usually be quickly resolved in a matter of minutes, simply by continuing to switch between 
covering the left and right eyes.  This procedure has been extended to couples therapy, and even 
to resolution of distorted body image with mirror work for patients afflicted with eating 
disorders. 
It is certainly not difficult to appreciate the value of such procedures, as they improve the 
therapeutic relationship (i.e., remove perceptual distortions that prevent experiences of trust and 
caring with the therapist).  So much research has been done that clearly demonstrates the 
centrality of therapeutic rapport to treatment outcome (explaining approximately 65% of the 
variance in treatment outcome).  One of the primary researchers and writers associated with this 
foundation in psychotherapeutic effectiveness is John Norcross (2010). 
  
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  107 
References 
Bradshaw, R. A., Cook, A., & McDonald, M. J. (2011). Observed & experiential integration 
(OEI): Discovery and development of a new set of trauma therapy techniques. Journal of 
Psychotherapy Integration, 21(2), 104-171. 
Clarkin, J. F., Yeomans, F. E., & Kernberg, O. F. (1999). Psychotherapy for borderline 
personality. New York: J. Wiley and Sons. 
Kernberg, O. F., Selzer, M. A., Koenigsberg, H. A., Carr, A. C., & Appelbaum, A. H. (1989). 
Psychodynamic psychotherapy of borderline patients. New York: Basic Books. 
Koenigsberg, H. W., Kernberg, O. F., Stone, M. H., Appelbaum, A. H., Yeomans, F. E., & 
Diamond, D. D. (2000). Borderline patients: Extending the limits of treatability. New 
York: Basic Books. 
Norcross, J. C. (2010). The therapeutic relationship. In Duncan, B. L., Miller, S. D., Wampold, 
B. E., & Hubble, M. A. (Eds.). The heart and soul of change: Delivering what works in 
therapy (2nd ed.), (pp. 113-141). Washington, DC: American Psychological Association. 
http://dx.doi.org/10.1037/12075-004  
Wieser, M. J., Pauli, P., Reicherts, P., & Mühlberger, A. (2010). Don't look at me in anger! 
Enhanced processing of angry faces in anticipation of public speaking. Psychophysiology, 
47(2), 271-280. doi:10.1111/j.1469-8986.2009.00938.x 
Yeomans, F. E., Clarkin J. F., & Kernberg, O. F. (2002). A primer of transference-focused 
psychotherapy for the borderline patient. Northvale, NJ: Jason Aronson. 
  
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  108 
APPENDIX F:  Participant Background Information 
 
The following information is to provide descriptive data about the participants in this study.   
 
1) What is your sex? Please circle.  
 
 Male   Female 
 
2) What is your gender (if different from above)? 
 
 
3) What is your Age?  Please write your date of birth (month/day/year) as well.  
 
4) What is your Ethnicity?  
 
5) What is your Culture? 
 
6) What is your religious affiliation?  
 
7) What is your highest level of education? Please circle.  
 
 ___ Less than Grade 10    ___ Bachelors Degree 
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 ___ Completed Grade 10    ___ Masters Degree 
 
 ___ High School Graduate or GED   ___ Ph. D, Doctorate, M.D.  
 
 ___ Some College/Associate Degree/Diploma ___ Other: _____________ 
  
8) What is your occupation?  
 
 
9)  Are you currently taking any medication? Please list below, including purposes.  
 
______________________________________________________________________________ 
 
______________________________________________________________________________ 
 
10)   Have you ever been hospitalized for mental health reasons?  __________________ 
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Electroencephalographic Information 
The following information will provide direction for the psychophysiological assessments. 
1) Dominant hand (circle)?  Right  Left 
2) Dominant eye (circle)?   Right  Left 
3) Nasion to Inion measurement? _______________ 
4) 50% of this for Nasion to Cz _______________ 
5) 10% of 3) above (for 10-20) _______________ 
6) 2 x 5) above (20% of 3) above _______________ 
 
 
--------------------------------------------------------------------------------------------------------------------- 
 
(Please Tear off This Portion of the Page and Refer to it Before Assessments) 
 
During electroencephalographic assessments, it is important for the electrodes (sensors on scalp) 
to make good contact.  For this reason, please avoid use of hair sprays and gels on assessment 
days. 
 
In addition, please avoid drinking beverages or eating foods that contain caffeine (coffee, tea, 
chocolate) for 2 hours before assessments. 
 
Thank you for your cooperation with these procedures. 
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APPENDIX G:  Dissociative Experiences Scale 
Eve Bernstein Carlson, Ph.D.  Frank W. Putnam, M.D. 
DIRECTIONS 
 
This questionnaire consists of twenty-eight questions about experiences that you may have in 
your daily life.  We are interested in how often you have these experiences in your daily life.  It 
is important, however, that your answers show how often these experiences happen to you when 
you are not under the influence of alcohol or drugs.  To answer the questions, please determine 
to what degree the experience described in the question applies to you and mark the line with a 
vertical slash at the appropriate place, as shown in the example below. 
 
Example: 
 
0%   l…......................................................./...........................................................l   100% 
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Date:________________  Age:  _________________  Sex:  M  F  ______________ 
 
1. Some people have the experience of driving a car and suddenly realizing that they don’t 
remember what has happened during all or part of the trip.  Mark the line to show what 
percentage of the time this happens to you. 
 
0%.......................................................................................100% 
 
2. Some people find that sometimes they are listening to someone talk and they suddenly 
realize that they did not hear part or all of what was said.  Mark the line to show what 
percentage of the time this happens to you. 
 
0%......................................................................................100% 
 
3. Some people have the experience of finding themselves in a place and having no idea 
how they got there. Mark the line to show what percentage of the time this happens to 
you.  
 
0%......................................................................................100% 
 
4. Some people have the experience of finding themselves dressed in clothes that they don’t 
remember putting on. Mark the line to show what percentage of the time this happens to 
you. 
 
0%......................................................................................100% 
 
5. Some people have the experience of finding new things among their belongings that they 
do not remember buying.  Mark the line to show what percentage of the time this happens 
to you. 
 
0%.......................................................................................100% 
 
6. Some people sometimes find that they are approached by people that they do not know 
who call them by another name or insist that they have met them before.  Mark the line to 
show what percentage of the time this happens to you. 
 
0%.......................................................................................100% 
 
7. Some people sometimes have the experience of feeling as though they are standing next 
to themselves or watching themselves do something and they actually see themselves as 
if they were looking at another person.  Mark the line to show what percentage of the 
time this happens to you. 
 
0%.......................................................................................100% 
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8. Some people are told that they sometimes do not recognize friends or family members.  
Mark the line to show what percentage of the time this happens to you. 
 
0%.......................................................................................100% 
 
9. Some people find that they have no memory for some important events in their lives (for 
example, a wedding or graduation).  Mark the line to show what percentage of the time 
this happens to you. 
 
0%.......................................................................................100% 
 
10. Some people have the experience of being accused of lying when they do not think that 
they have lied.  Mark the line to show what percentage of the time this happens to you. 
 
0%  ……………………………………………………… 100% 
 
11. Some people have the experience of looking in a mirror and not recognizing themselves.  
Mark the line to show what percentage of the time this happens to you. 
0%  ……………………………………………………….100% 
 
12. Some people have the experience of feeling that other people, objects, and the world 
around them are not real.  Mark the line to show what percentage of the time this happens 
to you. 
0%  ……………………………………………………….100% 
 
13. Some people have the experience of feeling that their body does not seem to belong to 
them.  Mark the line to show what percentage of the time this happens to you. 
0% ………………………………………………………..100% 
 
14. Some people have the experience of sometimes remembering a past event so vividly that 
they feel as if they were reliving that event.  Mark the line to show what percentage of the 
time this happens to you. 
 
0%......................................................................................100% 
 
15. Some people have the experience of not being sure whether things that they remember 
happening really did happen or whether they just dreamed them. Mark the line to show 
what percentage of the time this happens to you. 
 
0%................................................................................100% 
 
16. Some people have the experience of being in a familiar place but finding it strange and 
unfamiliar.  Mark the line to show what percentage of the time this happens to you. 
 
0%................................................................................100% 
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17. Some people find that when they are watching television or a movie they become so 
absorbed in the story they are unaware of other events happening around them.  Mark the 
line to show what percentage of the time this happens to you. 
0%................................................................................100% 
 
18. Some people find that they become so involved in a fantasy or daydream that it feels as 
though it were really happening to them.  Mark the line to show what percentage of the 
time this happens to you. 
 
0%................................................................................100% 
 
19. Some people find that they sometimes are able to ignore pain.  Mark the line to show 
what percentage of the time this happens to you. 
 
0%.................................................................................100% 
 
20. Some people find that they sometimes sit staring off into space, thinking of nothing and 
are not aware of the passage of time.  Mark the line to show what percentage of the time 
this happens to you. 
 
0%.................................................................................100% 
 
21. Some people sometimes find that when they are alone they talk out loud to themselves.  
Mark the line to show what percentage of the time this happens to you. 
0%....................................................................................100% 
 
22. Some people find that in one situation they may act so differently compared with another 
situation that they feel almost as if they are two different people.  Mark the line to show 
what percentage of the time this happens to you. 
 
0%....................................................................................100% 
 
23. Some people sometimes find that in certain situations they are able to do things with 
amazing ease and spontaneity that would usually be difficult for them (for example, 
sports, work, social situations, etc.).  Mark the line to show what percentage of the time 
this happens to you. 
 
0%..................................................................................100% 
 
24. Some people sometimes feel that they cannot remember whether they have done 
something or have just thought about doing that this (for example, not knowing whether 
they have just mailed a letter of have just thought about mailing it).  Mark the line to 
show what percentage of the time this happens to you. 
0%.................................................................................100% 
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25. Some people find evidence that they have done things that they do not remember doing.  
Mark the line to show what percentage of the time this happens to you. 
 
0%.................................................................................100% 
 
26. Some people sometimes find writings, drawings, or notes among their belongings that 
they must have done but cannot remember doing.  Mark the line to show what percentage 
of the time this happens to you. 
 
0%...............................................................................100% 
 
27. Some people sometimes find that they hear voices inside their head that tell them to do 
things or comment on things they are doing. Mark the line to show what percentage of 
the time this happens to you. 
 
0%...............................................................................100% 
 
28. Some people sometimes feel as if they are looking at the world through a fog so that 
people and objects appear far away or unclear.  Mark the line to show what percentage of 
the time this happens to you. 
 
 
  
 0%..........................................................................100% 
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To score:  Add percentages from all the questions together and divide by 28.  
If score is > 25 < 40 = BPD range. 
If score is > 40 = DID (MPD) range. 
 
But …. Actual dissociation could be much higher than reported due to client’s lack of awareness 
re:  his/her own dissociation.  In these cases you will usually see evidence of in it the oral 
administration. 
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APPENDIX H:  Personal Report of Confidence as a Speaker 
This instrument is composed of 30 items regarding your feelings of confidence as a speaker.  
After each question there is a “true” and “false.”  Try to decide whether “true” or “false” most 
represents your feelings associated with your most recent speech, then put a circle around the 
“true” or “false.”  Remember this information is completely confidential and will not be made 
known to any professors.  Work quickly and don’t spend much time on any one question.  Your 
first impression is what counts.  
   
T   F   I look forward to an opportunity to speak in public.     
T   F  My hands tremble when I try to handle objects during a speech. 
T   F  I am in constant fear of forgetting my speech.            
T   F  Audiences seem friendly when I address them. 
T   F  While preparing for a speech I am in a constant state of anxiety.  
T   F   At the conclusion of a speech I feel that I have had a pleasant   
       experience. 
T   F   I dislike to use my body and voice expressively.  
T   F   My thoughts become confused and jumbled when I speak before an                             
    audience.  
T   F   I have no fear facing an audience.  
T   F   Although I am nervous just before getting up to give a speech. 
T   F   I face the prospect of making a speech with complete confidence. 
T   F   I feel that I am in complete possession of myself while speaking.  
T   F   I prefer to have notes with me in case I forget my speech. 
T   F   I like to observe the reactions of my audience to my speech. 
T   F   Although I talk fluently with friends I am at a loss for words when                                  
    giving a speech. 
T   F   I feel relaxed and comfortable while speaking to an audience. 
T   F   Although I do not enjoy speaking in public I do not particularly dread it. 
T   F   I always avoid speaking in public if possible. 
T   F   The faces of the audience are blurred when I look at them. 
T   F   I feel disgusted with myself after trying to address a group. 
T   F   I enjoy preparing a talk. 
T   F   My mind is clear when I face an audience. 
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T   F   I am fairly fluent.  
T   F   I perspire and tense all the while I am speaking before an audience.  
T   F   My posture feels strained and unnatural when speaking to an audience.  
T   F   I am fearful and tense all the while I am speaking before a group.  
T   F   I find the prospect of speaking before a group mildly pleasant.  
T   F   It is difficult for me to calmly search my mind for the right words to  
    express my thoughts in front of a group.  
T   F   I am terrified at the thought of speaking before a group.  
T   F   I have a feeling of alertness in facing a group.  
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APPENDIX I:  Trauma Scene Form 
(for Script-Driven Symptom Provocation) 
 
We would like you to write a description of the most traumatic event you have experienced in 
your life associated with public speaking.  We may ask you more detail about this experience 
later. 
 
If you find it difficult to think of something to write, it may help to close your eyes and imagine 
yourself back in the situation.  Try to generate the same sensations and feelings that you 
experienced at the time.  While the image is vivid in your memory, jot down the details of the 
scene and the sensations you experienced at the time.  Also, on the next page are bodily 
experiences you may have had; please circle any that apply. 
 
Describe the traumatic situation.  Include such details as when it happened (age and date), where 
you were, who was there (names), what you were doing, how things looked, what you heard, 
what you were feeling, etc.  Please do not guess or include anything about which you are not 
positive. 
 
Please write things in the order they happened, and include bodily sensations from the next page 
at the appropriate times (turn the page to that first).  Continue your description on the reverse 
side of this page if necessary. 
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Listed below are a number of bodily sensations that people may experience in various 
situations.  Please circle all of the responses that you experienced in the situation you 
described, and include several in your description. 
 
 
heart stops     feel tense all over   jittery 
feel relaxed all over   butterflies in stomach   calm 
tension in forehead   cramps in stomach   clenched fist  
constriction in chest   tension in back     breath faster 
shallow breathing   breath slower    grit my teeth  
pant      clenched jaw    feel relaxed all over 
stomach is in a knot   gasping for air    heart skips a beat 
laboured breathing   tension in the arms    feel restless 
nauseous     feel tense all over   head pounds  
tension in forehead   tightness in the face   hands trembling 
heart pounds    heart beats slower   heart races 
heart quickens    feel sweaty     palms are clammy 
beads of perspiration   sweat pours out   arms & legs warm and relaxed 
feel warm     clenched fist    tension in back 
grit my teeth    clenched jaw    feel hot all over 
tension in the arms   flushed face    eyes water  
body feels heavy    eye twitches    eyes burn 
tightness in the face   hands trembling    eyes wide open 
whole body shakes   blood rushing to head  
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APPENDIX J:  EEG and EDA Protocol 
Electroencephalogram and Electrodermal Activity Assessment Script 
 
The exact sequence of recording sites and activities, in the Electroencephalogram and 
Electrodermal ActivityAssessment script, are as follows.  All measurements within each task are 
gathered during the same one minute period the task runs.  Each assessment is 3 minutes in total.  
 
Baseline Assessment 
 
Task 1 
Channel C: C4: Eyes Open (1 minute)  
Channel D: T4: Eyes Open (1 minute) 
Channel E: E1 & E2: Eyes Open (1 minute) 
 
Task 2 
Channel C: C4: Eyes Open (1 minute)  
Channel D: T4: Eyes Open (1 minute) 
Channel E: E1 & E2: Eyes Open (1 minute) 
 
Task 3 
Channel C: C4: Eyes Open (1 minute)  
Channel D: T4: Eyes Open (1 minute) 
Channel E: E1 & E2: Eyes Open (1 minute) 
 
Symptom Provocation Assessment 
 
Task 1 
Channel C: C4: Eyes Open (1 minute)  
Channel D: T4: Eyes Open (1 minute) 
Channel E: E1 & E2: Eyes Open (1 minute) 
 
Task 2 
Channel C: C4: Eyes Open (1 minute), play Script Driven Symptom Provocation Audio Track 
Channel D: T4: Eyes Open (1 minute), play Script Driven Symptom Provocation Audio Track 
Channel E: E1 & E2: Eyes Open (1 minute), play Script Driven Symptom Provocation Audio 
Track  
 
Task 3 
Channel C: C4: Eyes Open (1 minute)  
Channel D: T4: Eyes Open (1 minute) 
Channel E: E1 & E2: Eyes Open (1 minute) 
  
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  122 
APPENDIX K:  Timed Behavioural Checklist  
Behaviour Observed        Time Period 
 1 2 3 4 5 6 7 8 Σ 
1) Paces 
2) Sways 
3) Shuffles feet 
4) Knees tremble 
5) Extraneous arm/hand motion 
6) Arms rigid  
7) Hands restrained 
8) Hand tremors 
9) No eye contact 
10) Face muscles tense 
11)  Face “deadpan” 
12)  Face pale 
13) Face Flush 
14) Moistens lips 
15) Swallows  
16) Clears throat 
17) Breathes heavily 
18) Perspires 
19) Voice quivers 
20) Speech blocks or stammers 
21) Rate changes  
22) Topic Changes 
 
Total: 
  
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  123 
APPENDIX L:  Recruitment Poster 
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APPENDIX M:  Informed Consent Form 
Confidence to be Heard: An efficacy pilot study using Observed and Experiential Integration 
(OEI) for the treatment of anxiety related to public speaking 
Investigators 
 
Stephanie Hall 
 MA Counselling Psychology Program 
 Trinity Western University 
  
Dr. Richard Bradshaw 
 MA Counselling Psychology Program 
 Trinity Western University 
 
Mihaela Launeanu 
 MA Counselling Psychology Program 
 Trinity Western University 
  
Dr. Marvin McDonald 
MA Counselling Psychology 
Program 
 Trinity Western University 
  
Todd Dutka 
 Department of Psychology 
 Trinity Western University 
  
 
Andria Weiser 
PhD Clinical Psychology Program 
Antioch University 
 
Michele Gruenhage 
Bestmarriages.ca 
 
Laverna Wilk 
Bestmarriages.ca 
 
Dr. Julie Lane 
 School Psychologist  
 Maple Ridge School District 
  
Ya-Chun Chi 
 MA Counselling Psychology Program 
Trinity Western University 
 
Hannah Calayan 
 Undergraduate Psychology Student 
 Trinity Western University
  
 
 
Purpose of the Project 
 
Public speaking anxiety is exceptionally common, affecting one third of the population in 
community surveys (Kessler, Stein, & Berglund, 1998; Stein, Walker, & Forde, 1996).  
Observed & Experiential Integration (OEI) is a new treatment for psychological trauma 
(Bradshaw, Cook, & McDonald, 2011) which has been subjected to two randomized controlled 
trials (Bradshaw, McDonald, Grace, Detwiler, & Austin, 2014; Bradshaw, McDonald, Williams 
et al., in preparation) and found to be an effective treatment for Posttraumatic Stress Disorder 
(PTSD).  Another treatment that has been found to be effective for reducing PTSD is referred to 
as “BRAIN”, which stands for: Breathing, Relaxation, Autogenics, Imagery, and grounding.  In 
years of clinical practice, OEI and BRAIN have been used successfully to treat public speaking 
anxiety (usually in 1-7 sessions).  To follow up these promising clinical observations, this study 
constitutes the first formal investigation of OEI to treat public speaking anxiety.  Behavioural 
(actual public speaking analysis) and psychophysiological (brainwave and skin conductance) 
evaluations will supplement self-report (questionnaire and interview) measures. 
 
Procedures 
 
There will be two phases in the project:  
 
1. Treatment #1 – 2-hour small group information/practice session followed by seven individual 
sessions;  
2. Treatment #2 – 2-hour small group information/practice session followed by seven individual 
sessions; 
 
You will be randomly assigned to one of two groups: 1) Treatment #1 first, or 2) Treatment #2 
first.  You will complete pretreatment, posttreatment I, and posttreatment II assessments.  At 
each assessment, you will deliver a short (5-minute) prepared speech to a small audience (up to 
four people), and the video recordings of those talks will be analyzed for specific behaviours.  
During each assessment period, you will also complete two quantitative electroencephalographic 
assessments to assess brainwave activity, and two palmar electrodermal activity assessments (a) 
when relaxed, and (b) when anticipating giving a short speech.  These evaluations simply involve 
measuring tiny electrical signals from your scalp and from the palm of one of your hands.  
During the evaluations just prior to giving a short speech, you will also listen to a short (50-
second) audio recording from your own description of an event earlier in your life that was very 
stressful and involved public speaking.  Assessments will also include paper-and-pencil 
questionnaires, and short interviews.  Assessments will be delivered by trained individuals who 
are unaware of which treatment group you have been assigned to, so it will be very important 
during the assessments not to talk about (describe or name) the treatments you have received 
with the assessors. 
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Confidentiality 
 
Your identity, and all of your scores, will be kept confidential.  Only the Investigators and 
Research Assistants will have access to this information.  The one exception to this assurance 
involves attendance at the two 2-hour psychoeducational group sessions which you will attend 
with five other participants in the study.  Even though all participants are assuring that they will 
not disclose the identities of other participants, this cannot be guaranteed by the investigators in 
this research study.  You may choose to use a pseudonym during that group time if you are 
uncomfortable using your own first name.  All researchers and research assistants who have 
access to your confidential information will sign a confidentiality agreement to keep your 
identity and all of your information confidential.  All hard copies of data will be kept in a locked 
file cabinet in a locked room in a secure (locked at night) building.  All digital copies of data will 
be stored in a password-protected file on a password-locked computer.  After analysis of video 
recordings of speech tasks and assessment sessions involving brainwave recording, those video 
recordings will be deleted, and your data will only be saved by participant number.  The 
intention is to keep the data in that form for ongoing analysis over a period of 10 years from 
completion of the data collection portion of the study. 
 
Information disclosed in assessment and therapy sessions is confidential, with the following 
exceptions: Threat to self (suicide risk); Threat to other (homicide risk and duty to warn); 
Suspicion of child abuse; Intent to drive a motor vehicle while intoxicated by alcohol or drugs; or 
Intent to have unprotected sexual contact or share IV drug needles, when infected by HIV and/or 
diagnosed with AIDS; and court subpoena of records. 
Time Commitment  
 
In addition to the phases mentioned above, there are several stages in this study.  
 
The initial stage constitutes the screening process, during which a series of self-report 
instruments will be used to decide eligibility for the study.  This portion should take roughly an 
hour plus any time spent asking questions of, or responding to questions from, Research 
Assistants.  
 
Each assessment period will take approximately 4-7 hours, spread over two days.   
 
The group receiving Treatment #1 first, will receive a 2-hour psychoeducational session about 
Treatment #1, with time to practice those skills.  The group receiving Treatment #2 first, will 
receive a 2-hour psychoeducational session about Treatment #2, with time to practice those 
skills.   
 
You will then receive seven hours of individual treatment sessions. 
 
A second assessment period will follow, which will include a series of interview questions in 
addition to all of the measures used in the pretreatment assessment period. 
 
You will then receive a 2-hour psychoeducational session about the second treatment, followed 
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by seven hours of individual therapy with the second treatment (which will differ, depending on 
which group you have been assigned to). 
 
Finally, there will be a second posttreatment assessment period, during which you will be asked 
a series of interview questions about your views on the therapy you have received, and the other 
assessment instruments and procedures from the pretreatment assessment. 
 
At the end of the study, you are encouraged (but not required) to book an appointment with a 
research team member for a debriefing meeting.  These appointments typically last an hour. 
 
These stages add to a time commitment of 35 hours spread over four months from January 2016 
through April 2016.  
 
Potential Discomfort 
 
Since one of the treatments (OEI) involves movement of the eyes, if you suffer from any eye-
related condition that could be aggravated by eye movement (including brain surgery in the area 
of the eyes) it will be important to inform your OEI therapist in the study, who can consult with 
your ophthalmologist for his/her approval before proceeding with these techniques. 
 
As with any therapy involving assessment or treatment of anxiety or stress, you may experience 
psychological distress at some point as you recall events, people, and situations that upset you.  
During OEI we try to keep this distress as low as possible (moderate) while still allowing you to 
process the traumas that disturb you.  You will be asked to focus on those events, or on current 
feelings that are distressing, while you have both eyes open, and also while you have each eye 
open separately.   
 
During these OEI procedures, people sometimes experience transient symptoms such as 
headaches, visual distortions, and stomach or chest tension.  These generally fade within 30-60 
minutes, and more often within 5 minutes.  In addition, it is possible that recall of upsetting 
incidents will trigger numbing symptoms, such as feeling drowsy, light-headed, or tingling in 
your hands, face, or feet.  Again, such symptoms normally subside within 30-60 minutes and 
more commonly within 5-10 minutes.   
 
Based on clinical experience, these procedures are effective for reducing anxiety and stress 
symptoms.  It is reasonable to alleviate the intensity of many of your symptoms in 7 sessions, but 
if you have had many previous traumatic experiences, or if you have an extensive mental health 
history (e.g., hospitalization, suicidality, or bipolar disorder) you should not expect all of your 
psychological symptoms to be gone in such a relatively short course of treatment.  For this 
reason, it is very important to describe your mental health history, provide contact information 
for other health and mental health professionals from whom you have received care recently, and 
(at some point early in your treatment) sign a consent form for exchange of information between 
providers who may be addressing your psychological symptoms (e.g., psychologist, psychiatrist, 
other counsellor, or GP physician. 
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Benefits for You 
 
This is an opportunity to work through experiences which cause public speaking anxiety with a 
skilled therapist, free of charge.  The effects of this study are expected to improve your life by 
helping you to process anxiety related to public speaking, and enable you to enter skill-based 
programs (like Toastmasters) or to learn public speaking skills.  In the long run, this could 
improve your employment status, future education, income, and even satisfaction with your own 
abilities and goal achievement. 
You will also receive training in relaxation and grounding techniques which can help you 
manage stress in this, and other areas, of your life.  
 
Further Information 
 
If you have any questions or desire further information with respect to this study, you may 
contact Stephanie Hall or one of her associates at stephanie.hall@mytwu.ca. 
 
If you have any concerns about your treatment or rights as a research participant, you may 
contact Ms. Sue Funk in the Office of Research, Trinity Western University at 604-513-2142 or 
sue.funk@twu.ca. 
 
Even after you consent to participate in this study by signing below, you may choose to stop 
doing OEI or any other treatment, at any time, without consequence.  In order to withdraw from 
the study you must simply notify the Principal Investigator, Stephanie Hall, in writing.  Your 
signature below affirms that you have read and understood the description of the therapy, and 
you willingly consent to the use of these procedures to reduce your posttraumatic distress related 
to public speaking anxiety and other anxiety-related problems. 
 
If you withdraw from the study, data collected from you will be stored in the same confidential 
way described earlier in this consent form.  
 
 
Your signature below indicates that you have had your questions about the study answered to 
your satisfaction, and have received a copy of this consent form for your own records. 
 
Your signature indicates that you consent to participate in this study, and that your responses 
may be put in anonymous form and kept for further use for 10 years, after the completion of this 
study. 
 
 
Name: ________________________________ Date: __________________________ 
 
 
Witness: ______________________________ Date: __________________________ 
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APPENDIX N – Palm Electrode Placement 
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APPENDIX O:  OEI Power Point Information 
Observed & Experiential Integration (OEI): To Resolve Public Speaking Anxiety 
 
Audrey Cook, MPhil 
Rick Bradshaw, PhD 
 
Public Speaking Anxiety Starts with Relational Trauma: 
a. Criticism & Rejection 
b. Humiliation/Embarassment 
i. Presentations in Classes 
ii. Recitals & Performances 
iii. Team or Club Activities 
iv. First Group: Starting School 
 
Now gets triggered: 
• Standing up front 
• Faces of Many People 
• Eyes Looking at You 
• Any Performance 
• Authority Figures 
 
Trauma Is… 
Negative Unexpected Makes You Feel: 
Powerless, Confused, or Out of Control 
 
Broca’s Area: Speech Production 
 
Limbic & Paralimbic Structures 
• The parts of the brain most involved in producing intense symptoms, like: 
• Panic, flashbacks, startle response, nausea, and throat or chest constriction 
• Are not directly affected by talking or listening 
 
Limbic System: Midbrain 
 
Anterior Cingulate Gyrus 
 
5 Building Blocks of OEI 
Level I Techniques 
• Switch 
• Sweep 
• Release Points 
Level II Techniques  
• Glitch Hold 
• Glitch Massage 
 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  131 
Core Trauma vs Dissociative Artefacts 
CORE TRAUMA SYMPTOMS (Fight, Flight, or Freeze) 
• Constriction in Throat (Airway)  
• Bronchoconstriction in Chest 
• Nausea or Queasiness in Stomach 
• Racing Heart Rate, Rapid Breathing, Perspiration, Shaking, Fear/Anxiety 
 *Note that all of these symptoms are experiencedin the core of the body…(hence CORE 
DISSOCIATIVE ARTEFACTS (Side Effects of Processing Intensity) 
• Headaches & Pressure in the Head 
• Visual Distortions, Blocks, & Blurring 
• Dizziness, Drowsiness, Loss of Balance 
• Tingling & Numbness in the Hands, Face, & Feet 
• Yawning 
• Sinus Pressure 
 
Video Demo – Public Speaking 
• Switching to reduce trauma intensity 
• Glitch massage to resolve points of intensity, using the eyes to access past relational traumas 
 
Examples - Transference 
• Audience Member Faces 
• Group Leaders 
• Photographs 
• Mirrors 
 
Eye Dominance Check 
Arms Length, Two Fingers Vertical, Both Eyes Open 
Line up vertical fingers with straight edge in distance 
Without moving fingers, close one eye, then open it 
Without moving fingers, close the other eye, then open it 
Which eye was open when the straight edge was in line? 
 
Many people report: higher levels of shock/fear/anxiety with their dominant eye open higher 
levels of sadness/despair/hopelessness with the other eye open 
 
Activity: Try This in Pairs  
Transference Check & Clearance 
• Proximity: Notice how far away I appear to you 
• Appearance: Notice how I look to you (color, expression) 
• Body/Emotion: Notice how you feel physically & emotionally 
• Cognitive Proj: Notice whether it seems like I’m on your side… 
Try sitting, standing, different people (gender, race, age, etc.) 
Try moving a small amount closer, further away, diff. angles 
 
Polyvagal Theory: Stephen Porges (2001/2007) 3 Response Levels 
Social Connection - Ventral Vagal Brake “On” 
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Fight-or-Flight - Ventral Vagal Brake “Off” (SNS) 
Freeze - Dorsal Vagal Complex – (DVC) 
 
 
 
Coactivation of SNS & PNS  
• “Tonic Immobility” = co-activation of Sympathetic & Parasympathetic Nervous Systems 
• In “Freeze” response, frequently changing pupil widths and increases in pulse rate from 60-70 
to 110-120 ppm 
• Childhood sexual abuse = 50% 
• Sexual assault victims 35-40 % some immobility 
 
 
Classical Conditioning of Trauma 
 
 
Ocular Proprioception: Angle/Direction/Movement Pattern 
Proprioceptors = Nerve cells in muscles sending signals to the brain about muscle positioning. 
   
Exist in large numbers and high densities in 6 muscles outside the eyes that control the 
movements of each eye & the neck. 
   
Individual cells fire in response to eye movements tracking objects.  Curved movements start 
from a different area of the brain than straight vertical, horizontal, or diagonal eye movements. 
 
 
Vertical Location in Visual Fields 
 
Occular Proprioception 
String demo 
“Like pulling out a sliver” 
 
Ocular proprioception - Distance 
Muscles inside the eyes control:  
• Curve & thickness of lenses  
• Constriction & dilation of pupils. 
  
What you: 
• Sense in your body 
• Hear 
• See 
• Smell 
• Feel emotionally  
 
Gets associated into patterns that occurred during events, that are recorded in the brain, then 
retrieved & re-mapped on muscles when you recall those events – creating “glitches”. 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  133 
 
Live Demo 
Therapist will comment on breathing, reddening of eyes (Social Biofeedback, Attunement) 
Glitch “massage” w distal pulls & other movement patterns 
Resolutions of Intensity with “Switching” & “Glitch Work”: 
• “Glitch Work”, like running the water into the sink from the tap 
• “Switching”, like pulling the plug and draining the sink of water 
 
Proximal-distal 
• Usually massaging toward the eyes triggers abuse 
• Sometimes massaging away triggers abandonment 
• Track across the visual field until you see a “glitch” 
• Then move vertically until you see another halt or skip 
• Then pull out of the centre of that “cross-hair” ( + ) 
• Keep going until you feel a fluttering of the eyes 
• There is often a breath release and shoulder drop 
• Sometimes there is an emotional release as well 
 
 
Release Points 
 
 
Peak Performance & Homework 
Use OEI Techniques at Home or at Work --- on Yourself! 
• Think about public speaking in front of an audience. 
• Focus on the images and sounds in your mind vividly. 
• If necessary, talk out loud about the situation you face! 
• When you feel physical & emotional intensity, Switch (eyes) 
• Stay longer with the eye open that’s LESS INTENSE, then Switch 
• Another way: Vividly imagine what you want to be able to do… 
• Notice what gets in the way (thoughts, emotions, sensations) 
• Focus on those blocks and Switch or do Glitch Work on yourself 
 
 
More Info on OEI 
 
Visit our Web site for FAQ videos, books, seminars, resources, memberships, Web site listing of 
clinicians, research summaries, information on OEI publications 
 
www.sightpsychology.com  
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APPENDIX P:  OEI Homework Exercises 
OEI Homework Exercises 
A. 
Already Intense & Thinking About Anxiety 
 Think about public speaking in front of an audience. 
 Focus on the images and sounds in your mind vividly. 
 If necessary, talk out loud about the situation you face! 
 When you feel physical & emotional intensity, Switch (eyes) 
 Stay longer with the eye open that’s LESS INTENSE, then Switch 
B. 
“Peak Performance” Approach to OEI Targets 
 Vividly imagine what you want to be able to do…(verbally fluid, confident) 
 Notice what gets in the way of that goal (thoughts, emotions, sensations) 
 Focus on those blocks or interferences and Switch or do Glitch Work 
 Go back to A. (Above) to pull down the intensity of the interferences 
______________________________________________________________________________
_______ 
Remember… 
• When you’re already intense (anticipational anxiety), cover your dominant eye 
• Wait until intensity subsides and you get a spontaneous breath release, then… 
• Return briefly to the dominant eye (open), feel the intensity and Switch again 
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If: 
• You get headaches, head pressure, tingling & numbness (hands/face/feet) 
Or: 
• Visual side effects (blurring, grey or black blobs in visual fields, double vision) 
Then: 
• Focus on side effects and Switch (eyes) or Sweep (from ears toward nose) 
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APPENDIX Q:  Helpful Aspects of Therapy Questionnaire (HAT) 
 
Name (pseudonym): _____________________________  Date __________________________     
 
Thank you for taking the time to fill in the information requested on this form.  Please note that 
you have the right to choose not to share any information that you choose not to share, and the 
right to withdraw your participation from this study. 
  
1. Of what happened in this session, what do you feel was the most helpful or important for you?  
(By that we mean something that happened in the session.  It might be something you said or did 
or something the therapist said or did.)  
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2. Please explain what made this event helpful/important and what you got out of it.  
  
  
  
  
 3. How helpful was this particular event?  Rate it on the following scale.  (Put an "X" at the 
appropriate point; half-point ratings are OK; e.g., 7.5.)  
 
   
 
  
 
 
4. About where in the session did this event occur?  
  
  
 
5. About how long did the event last?   
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6. Did anything else particularly helpful happen during this session?  
 ☐ Yes   ☐  No    
 a) If yes, please rate how helpful this event was: ☐  Slightly helpful  
        ☐  Moderately helpful  
        ☐  Greatly helpful  
        ☐  Extremely helpful  
 
 b) Please describe the event briefly:  
 
 
 
 
 
  
7. Did anything happen during the session that might have been hindering or not helpful? 
 ☐ Yes   ☐  No    
 a) If yes, please rate how hindering the event was: ☐  Extremely hindering  
        ☐  Greatly hindering  
        ☐  Moderately hindering  
        ☐  Slightly hindering  
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 b) Please describe this event briefly: 
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APPENDIX R:  BRAIN Power Point Information 
B.R.A.I.N.  	
Treatment Techniques for Public Speaking Anxiety 
Breathing, Relaxation, Autogenics, Imagery, & grouNding  
 
Breathing 
 
Breath Support 
2) Public Speaking = Projection of Your Voice 
3) Anxiety = Shortness/Shallowness of Breath 
4) Diaphragmatic Breathing = More Oxygen 
5) Diaphragmatic Breathing = More Relaxation 
 
Chest (Thoracic) Breathing: Photo Example 
Diaphragmatic Breathing: Photo Example 
 
Diaphragmatic Breathing Exercise 
• Chest (thoracic) breathing vs. abdominal (diaphragmatic) breathing 
• Hand on stomach should rise more than hand on chest 
• “breathe in relaxation…breathe out tension” 
 
Progressive Muscle Relaxation 
 
Progressive Muscle Relaxation  
 
Progressive Muscle Relaxation for Public Speaking Requires “Natural” Relaxed Gestures 
• “Fight-or-Flight” response causes muscle tension  
• Learn to sense the difference between tense muscles and relaxed ones 
 
Muscle Relaxation (Hands): Video Example 
 
Muscle Group Relaxation 
• Head, face, throat & shoulders 
•  Chest, stomach & lower back 
•  Thighs, buttocks, calves & feet 
•  Hands, forearms, & biceps 
• Tense for 5 sec.  Release for 20 sec. 
 
Autogenics 
 
Autogenics = Opposite of Fight/Flight  
• Central Nervous System = Brain & Spinal Cord 
• Peripheral Nervous System = SNS + ANS 
 Somatic Nervous System = Voluntary Muscles 
 Autonomic Nervous System = Involuntary Muscles  
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 Sympathetic Division - Fight-or-Flight Response 
 Parasympathetic Division - Relaxation Response 
 
Autogenics (CNS vs ANS): Anatomic Diagram 
Sympathetic vs Parasympathetic: Anatomic Diagram of Organs Effected  
Autogenics (with Respiratory Synchronization) 
• My breathing is deep and slow 
• My heartbeat is slow and regular 
• My hands and arms are so warm and so heavy 
• My feet and legs are so warm and so heavy 
• My forehead is cool and dry 
 
Imagery 
 
Positive Mental Imagery = Relaxation  
• Positive Multisensory Mental Imagery 
 What do you see?  Hear?  Feel in your body? 
• Core Person/Safe Place Exercise 
 Pair Autogenics with Multisensory Imagery 
• Create Protection Around the “Safe Place” 
 
Your brain doesn’t know the difference between the real thing (e.g., favourite food) and a mental 
image of that thing. 
 
The same response is generated (saliva, etc) 
 
CORE PERSON / SAFE PLACE EXERCISE 
(“Visualize the most calm, safe place you have experienced or can imagine”) 
Autogenics                                           
• My hands & arms are warm & heavy 
• My breathing is deep & slow 
• My heartbeat is slow & regular 
• My feet & legs are warm & heavy 
• My forehead is cool & dry 
Multisensory Imagery 
• What do you see? (movement, colour) 
• What do you hear? (waves, nature) 
• What do you feel? (wind, sun, water) 
• What do you smell? (fragrance) 
• What do you taste? (drink, food) 
 
Images of A Successful Speech 
You can also imagine (using all your senses) giving a wonderful speech.  See the looks of 
emotion on the faces of audience members.  Hear the applause when you are done!  Walk 
through and mentally rehearse every detail, from walking onto the stage, to confidently stepping 
down.  Olympic athletes use this when preparing for their events (gymnastics, skiing, high 
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diving) because it works!  
 
Multisensory Imagery 
The brain has motor areas to actually trigger movement of the muscles.  It also has pre-motor 
areas that organize the movement sequences and help with muscle memory. 
 
There was a champion golfer who was captured as a prisoner of war.  He would go through the 
18 holes of a golf game each day in his mind.  When released, he played better than he had 
before he went in! 
 
Grounding 
 
Grounding: Reconnect to the World in the moment 
Not worrying about future performances 
 
Sensate Focus – One Sense at a Time 
 
Cook’s Hook-Ups & Cross-Crawl 
Restores Hemispheric Balance in Brain 
Lowers Distress 
 
 
Grounding – Sensate Focus 
What do you  hear? 
What do you see? 
What do you feel (touch)? 
What do you smell? 
What do you taste? 
 
 
Hearing & Seeing 
While waiting to get up and speak, just close your eyes and concentrate ONLY on what you hear 
(air conditioning, voices, etc). 
 
While sitting in the audience or backstage, find some colour or object (or person) that is calming 
and make that your focus. 
 
 
Tasting & Touching 
Take a favourite flavour of gum or hard candy with you and pop some in your mouth while 
waiting.  Focus your mind completely on the taste and texture. 
 
Feel the arm of the chair you are in.  Feel your feet on the floor, or your back against the chair 
you are sitting in.  Focus ONLY on those sensations --- in the moment! 
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Smell -  A Magical Sense for Calming 
5 senses: (sight, hearing, touch, taste, & smell) 
  
4 of the 5 senses are processed through the Thalamus (sensory processor) first, but… 
 
One sense is processed through the Amygdala (emotion processor) first…SMELL 
 
 
Brain Image:  
Olfactory Bulb Amygdala  
Smell = Emotion Processor  
Positive Smells Instantly Calm the Emotions 
 
Floral:  
• Rose 
• Lavender 
• Champa 
 
Citrus:  
• Lime 
• Lemon  
• Orange 
 
Wood:  
• Cedar 
• Pine 
• Spruce 
 
Spice:  
• Clove 
• Cinnamon 
• Vanilla  
 
Get Smells! 
• Bring a small bottle of scented oil from three groups of smells (floral, citrus, wood) 
• Put a few drops on some Kleenex tissue 
• Breathe in the fragrance while waiting to give a speech or perform and it will calm your 
emotion processor deep in your brain quickly! 
 
 
Grounding – Cook’s Hook-ups 
• Cross left leg over right with right leg perpendicular to the floor. 
• Take right hand and grasp shin between knee and ankle. 
• Cross left hand and arm over right hand and arm, and grasp shin closer to ankle 
 
You can do this procedure while sitting and waiting to give a speech or perform and it will help 
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keep you calm until you go on stage! 
 
No one can tell what you are doing, because it looks like you are just sitting comfortably with 
your legs crossed! 
 
 
Grounding (Cross-Crawl): Photo Example 
 
You can do a subtle version of this while sitting: Just cross your arms on your lap and alternately 
tap the insides or backs of your legs just above your knees. 
 
This is so unobtrusive that you can do it any time while you are waiting to get up and speak. 
 
 
More Information on BRAIN? 
 
The Relaxation & Stress Reduction Workbook by Martha Davis, Elizabeth Robbins Eshleman & 
Matthew McKay Oakland, California: New Harbinger Publications 
 
Brain Gym: Simple Activities for Whole Brain Learning by Paul Erlich Dennison & Gail E. 
Dennison Edu-Kinesthetics 
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APPENDIX S:  BRAIN Techniques 
Breathing Relaxation Autogenics Imagery GrouNing 
Script for All-Participant Audiotape 
prepared by 
Rick Bradshaw, Ph.D. 
recorded by 
Marie Amos, M.A. (Cand.) 
Before your start your relaxation session, locate the Amos Relaxation Effectiveness Tracking 
Chart and enter the numbers for your “Emotional State (Before)”, “Physical State (Before)” and 
“Overall Distress Level (Before)” for the current day of the month. 
 
Good times for this relaxation session may be just before or after dinner, or just before bed.  Find 
a safe, calm, quiet place with the lights dimmed….and a comfortable, warm temperature.  You 
may want to use scented oils or candles with soothing fragrances.  It might be nice to use pillows 
or cushions under or around you. 
 
Start by getting into a comfortable position, sitting or lying down.  Place your hand on your 
abdomen.  As you breathe in, allow your abdomen to rise, lifting your hand.  As you breathe out, 
allow your hand to lower with your abdomen, as it returns to its original position.  Continue this 
process, inhaling and exhaling deeply.  Close your eyes and take a deep breath in.  Breathe in 
relaxation, and breathe out tension.  Allow yourself to sigh gently, as the air flows from your 
lungs. 
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With each breath, search your body for tension, and melt it away.  Allow yourself to sink back 
into the chair, couch or bed, feeling the support under you.  As you relax, follow your breathing.  
Go to the deepest, calmest place inside… 
 
Notice your hands… With each breath release more tension in your hands…now release the 
muscles in your forearms…imagine the tension floating off your forearms…and now your 
biceps.  Let your arms fall to your sides or in your lap, and relax your biceps.  Imagine a warm, 
flowing current…with each breath, melting more of the tension away…----…soothing and 
smoothing the muscles…calming.  Now notice the muscles in your head and face…allow the 
tension to float up off your forehead and soften the skin around your eyes…Now notice your 
jaw.  Let it slacken, and allow your mouth to open comfortably and relax.   
 
Next, relax your throat…”Melt away” tension in your throat, neck, and shoulders.  Go through 
each of these areas, and release more tension each time you exhale…… Let go of the tension in 
your face and jaw …Lift the tension off your forehead and face.  Llet it slowly melt away from 
your neck and shoulders.  Let the tension dissolve away.  Continue down your body…”letting 
go” of tension and “breathing in” relaxation…to your chest…slowly …your stomach…and your 
lower back.  Finally, release the tension in your lower body…with each breath …Relax and 
smooth the muscles… to your feet….Let the tension flow out of your feet.  Allow the tension to 
flow out of your body, from the top of your head all the way down, and out though your feet.  
Let go more…and more…keep releasing tension as you breathe, until you find absolutely no 
trace of tension in your muscles. 
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Now that you’re deeply relaxed, go in your mind to your own special retreat for relaxation and 
rest.  It can be indoors or out. You’ll need a private entry or pathway, and it should be peaceful, 
comfortable and safe.  Create protection around you and over you, in your mind. Try imagining a 
large, in the distance.  As you spend time in that place, gradually become aware of the sound of 
water & wind.  Allow the wind and gentle waves to ebb & flow in time with your breathing… 
perfectly synchronized with your breathing in…and breathing out…deep, full, relaxing 
breaths…Your breathing is deep… and…slow-w-w…and your heartbeat is slow-w-w…and… 
regular… 
 
Feel the sun on your skin…If you’re inside, notice the warmth of the room…Your hands…and 
arms…are so-o-o warm, and so-o-o heavy…and your feet and legs…so-o-o warm…and so-o-o 
heavy… 
 
There’s a gentle breeze… through your hair… through the trees… and over your forehead.  Your 
forehead…is cool…and…dry-y-y…. A beautiful fragrance is floating on the 
breeze…calming…soothing, peaceful…The fragrance takes you back in your mind to a time 
when you rested safely…effortlessly…to a place where you were restored and felt fully alive, in 
the most positive way… 
 
Continue to spend time in that calm, restful, safe place…breathing in---deeply, and breathing 
out---fully.  Breathing is deep…and… slow.  Heartbeat is slow…and…regular…Notice the 
colours & movement in that place.  Choosing the most calming, soothing colour…and allowing 
that colour to go all through your body, from the top of your head to the tips of your fingers and 
toes….. 
RESEARCH PROTOCOL DEVELOPMENT FOR SAD  148 
As you focus on that color, allow music or sounds to enter your mind that go most naturally 
with the soothing colour.  Let that music or sound go all through your body, from the top of your 
head to the tips of your toes. 
 
Focus on the colour, sound, and calm, confident feeling, and think of an object or shape and 
movement that goes with those feelings, thoughts and images.  It might be soaring, bubbling, or 
moving effortlessly in slow motion…Just focus on that sense of movement, and feel it all through 
your body.  Also notice the temperature that’s most comfortable.   
 
Your hands…and arms… are so-o-o warm, and so-o-o heavy… …feet and legs…so-o-o 
warm…and so-o-o heavy…forehead…is cool…and…dry-y-y…. That beautiful fragrance is 
floating on the breeze…calming…soothing…peaceful… 
 
Become aware of all your senses.  Notice which sense activates the rest.  It might be 
colour…sound…movement… shape… temperature…fragrance…or touch.  Focus on one of 
your senses in your environment right now…what you hear…or see…or textures & temperatures 
you feel with your hands…Block out all of the other senses and just focus…second-by-
second…on what you become aware of…as if you’re noticing life “floating gently by” on a 
slow-moving river…Feel the support of the chair, couch or bed under you…Feel the weight of 
your feet and hands… 
 
Enjoy more time in your safe, special place: The colours, movement, sounds, fragrances and 
temperature all combine to create a restful, relaxing experience.  Breathing in relaxation, and 
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breathing out tension.  Consider returning to the room you started your relaxation session 
in….gradually, at your own pace.  There’s no rush….Start noticing the sounds in the room and 
outside…. 
. 
Cross one leg over the other…and then cross your forearms on the leg that is crossed over the 
lower leg...holding the shin closest to you with both hands.  Remember “Cook’s Hook-ups”.  
Allow a deep sense of peacefulness and relaxation to flow over you… calming… 
soothing…restoring.  Remember those feelings as you come back and continue your day or 
evening.  Take that relaxation with you… 
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APPENDIX T:  Credibility of Treatment Questionnaire  
 
Please circle the corresponding number to answer these questions.  
 
6)   How logical does this type of treatment seem to you? 
 
  1            2           3            4            5            6            7            8            9            10 
Not Logical           Very Logical 
 
 
 
2) How confident are you that this treatment will be successful in eliminating the symptoms of 
Public Speaking Anxiety? 
 
 1            2           3            4            5            6            7            8            9            10 
Not Confident           Very Confident 
 
 
 
 
3) How confident would you be in recommending this treatment to a friend who was suffering 
from the symptoms of Public Speaking Anxiety? 
 
 1            2           3            4            5            6            7            8            9            10 
Not Confident           Very Confident 
 
 
 
 
4) If you were suffering from extremely high levels of Public Speaking Anxiety symptoms, 
would you be willing to undergo such treatment? 
 
 1            2           3            4            5            6            7            8            9            10 
Not Willing           Very Willing 
 
 
 
5) How successful do you think this treatment would be in decreasing the symptoms of a 
different anxiety disorder, such as Social Anxiety? 
 
 1            2           3            4            5            6            7            8            9            10 
Not Successful           Very Successful 
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APPENDIX U:  Post-Treatment Interview 
Interview Questions for Posttreatment Assessment #1 
 
Ask each participant the following questions1.  Printed in bold are the actual words to ask the 
participants and italic print gives directions to the interviewer. 
 
Now I am going to ask you some questions about your therapeutic experience and I will be 
recording our conversation.  Please be honest and give as much detail in response to each 
question as you see fit.  Do you have any questions before we start?  (If they have questions, 
answer them, make a mental note of the question(s), then proceed to Question #1; if they have no 
questions proceed to Question #1) 
 
1. How are you doing now as compared to when you entered the study?  
 
2. In what way if any was the therapy helpful to you? 
 
3. Did it have any effect on the issues that you wanted to address?  
a. If the participant answered yes to #3, ask them: Do you think that the benefits 
gained will be lasting?  
 
4. Did the therapy affect anything else? 
 
5. Were you surprised by anything that has happened since you began the study? 
 
6. Do you think you will need more therapy to resolve your public speaking issues? 
 
                                                
1 Questions 1-8 are taken directly from Edmond et al. (2004), p. 264.  The remaining questions were added for this 
project. 
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7. What are your thoughts and feelings about your therapist now? 
 
8. How did the therapy that you received in the study compare to other therapy or 
counselling that you have received? 
 
9. What did you like or value the most about the therapy you received? 
 
10. What did you dislike or find least valuable about the therapy you received? 
 
11.  Either Option “a” or Option “b” is to be used for this question. DO NOT ASK BOTH 
OPTIONS! 
 
a. If the participant has mentioned in any of the previous questions anything about 
extra-therapeutic factors (relationships, family, overall disposition, etc.) that are 
better ask them: Earlier you mentioned _______ (insert the extra-therapeutic 
factor they mentioned earlier) Can you tell me more about that? 
i. Ask this in follow up to Option “a” Is there anything else that has 
affected your life over the last few months besides therapy? 
 
b. If the participant did not mention anything in the previous questions about 
positive impacts on extra-therapeutic factors or they only mentioned negative 
effects of the therapy, ask them: So far we have been talking about the therapy 
you received.  Now I would like to ask you a more general question, okay? 
Wait for the participant to respond in the affirmative, and then ask them: What 
has been helpful for you over the last few months besides therapy? 
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APPENDIX V: Descriptive Statistics 
PRCS Descriptive Statistics 
 Experimental Group Mean Std. Deviation N 
Pre-treatment OEI 20.60 3.29 5 
 BRAIN 22.75 6.08 4 
 Total 21.56 4.53 9 
Post-Treatment OEI 16.00 6.29 5 
 BRAIN 16.50 8.19 4 
 Total 16.22 6.70 9 
 
 
BDI-II Descriptive Statistics 
 Experimental Group Mean Std. Deviation N 
Pre-treatment OEI 6.80 2.49 5 
 BRAIN 8.25 8.26 4 
 Total 7.44 5.41 9 
Post-treatment OEI 1.80 1.79 5 
 BRAIN 11.25 6.99 4 
 Total 6.00 6.10 9 
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BAI Descriptive Statistics 
 Experimental Group Mean Std. Deviation N 
Pre-Treatment OEI 7.00 3.94 5 
 BRAIN 9.33 0.58 4 
 Total 7.88 3.23 9 
Post-Treatment OEI 4.20 2.39 5 
 BRAIN 10.67 2.89 4 
 Total 6.00 4.10 9 
 
 
TBC Descriptive Statistics 
 Experimental Group Mean Std. Deviation N 
Pre-treatment OEI 36.90 10.79 5 
 BRAIN 43.75 10.28 4 
 Total 39.94 10.53 9 
Post-treatment OEI 23.00 11.42 5 
 BRAIN 29.63 11.78 4 
 Total 25.94 11.37 9 
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APPENDIX W: Treatment and Assessment Protocol Development for Performance Specific 
Social Anxiety Disorder based on Symptom Type and Treatment Strategy. 
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Note:  Treatment Activated Processes are presented as concentric circles where one encapsulates 
the contents of the other.  The Symptom circles represent categories.  Each of the measurement 
instruments employed in this project are placed in the diagram.   
